Relentless Curesfor the 2000 Annual Report Our Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patientsmissi and their families.
Our name
We added the word “lymphoma” to our name last year to bring into focus the full scope of our mission–fighting all hematological malignancies. The Society was further motivated by a startling rise in lymphoma incidence rates over the last two decades. For all these blood-related cancers, we have been, and will continue to be, relentless for the cures. www.leukemia-lymphoma.org 3
Survival rates
Leukemia 14% 44%
Non-Hodgkin’s Lymphoma 31% 52%
Hodgkin’s Disease 40% 83%
Myeloma <5%
Survival rates 28% on 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Status of blood 1960 1995
related cancers: Sources: National Cancer Institute Seer Data; Myeloma: Biology and Management, 2nd Edition, Oxford University Press, 1998. Leukemia We’re winning the battle…The five- But the war isn’t over… About year survival rate for leukemia 62,300 Americans will be diagnosed patients has tripled from 14% in with lymphoma in 2000, the vast 1960, to 44% in 1995. The five-year majority with non-Hodgkin’s survival rate for children with acute lymphoma. An estimated 27,500 lymphocytic leukemia is 81%. people will die from lymphoma in 2000, the majority from non- But the war isn’t over…This year in Hodgkin’s lymphoma. the U.S., an estimated 30,800 new cases of leukemia will be diagnosed, Myeloma and approximately 21,700 people will We’re making progress… The die from the disease. survival rate for myeloma is 28%, a modest improvement from 24% in Lymphoma the 1970s. We’re winning the battle… The five- year survival rate for non-Hodgkin’s But there’s much more we need to lymphoma patients rose from 31% do… An estimated 13,600 new cases in 1960 to 52% in 1995. In children, of myeloma will be diagnosed in the the five-year survival rate is 78%, a U.S. in 2000, and approximately significant improvement in the last 11,200 people will die from it. 30 years. 4
Relentless for the cures
Relentless for the cures. It means that nothing will stand in the way of those determined to carry out the Society’s mission. The record this year, as well as future plans, attest to this ongoing commitment.
Take a look at the Society’s research In patient services, you’ll find “relentless” programs. The relentless pursuit of in the Information Resource Center cures can be found, for example, in programs—lifelines of emotional support the promising therapy developed by and timely professional guidance for tens Society Officers (l-r) Dr. Brian Druker to treat chronic of thousands of patients. And through its Jay L. Silver, Chairman; Richard A. Fess, Secretary/Treasurer; Dwayne Howell, myelogenous leukemia. All 31 patients web site and the Internet, the Society President and CEO; W. Stratford May, Jr., treated in the initial clinical trials have speeds the delivery of vital information MD, PhD, Vice Chairman, Medical and Scientific Affairs; Peter J. Quesenberry, had their blood counts return to normal, and services, and engages patients and MD, Vice Chairman. so the trials have expanded to more volunteers more efficiently. In a very than 1,500 patients—and we are real sense, the Internet is providing the very optimistic. Society with an increasing presence and greater capacity to expand the reach of Take a look at our new SCOR program its mission. (Specialized Center of Research), with $22.5 million targeted to three groups of The supporters of the Society are also scientists working cooperatively on a relentless about raising the money that range of research to fight blood-related fuels these programs, having increased cancers. We expect to triple this program the Society’s net revenue by 24% this year over the next few years. to a record $133.4 million. In fact, in terms Rele for the cur
www.leukemia-lymphoma.org 5
of share of donations raised, the Society Today, more people are surviving blood- continues to be the fastest growing related cancers than ever before, but it’s nationwide voluntary health organization not enough. With powerful new tools and in the U.S. How did we get there? Look a growing array of new programs and at the national Light The Night® Walk services, the volunteers and staff of the campaign, which raised $5 million in fiscal Society are truly relentless for the cures. year 2000 and nearly twice that amount Nothing will stand in their way. this year. Or talk to people like Harry Pearce, Vice Chairman of General Motors, who is launching a personal campaign to raise millions of new dollars for research. Jay L. Silver Chairman Of course, nothing says relentless more than Society volunteers—individuals, families and business owners, trustees The Society continues to at every chapter, and even renowned Dwayne Howell be the fastest growing scientists who spend countless hours of President and CEO “ nationwide voluntary health “free” time assessing research proposals. organization in the U.S. ” ntless es
(l-r) Richard A. Fess, Peter J. Quesenberry, MD, Jay Silver, Dwayne Howell, W. Stratford May Jr., MD, PhD 6
How you can help
• Support research programs by volunteering with the Society • Raise and contribute funds for research Stren research
Strengthening research— the SCOR grants The Leukemia & Lymphoma Society’s new Specialized Center of Research (SCOR) Program will provide $22.5 million in research grants over five years, to three groups of outstanding scientists working on blood-related cancers.
In addition to the three grants designated The SCOR at Weill Medical College of for 2000 - 2001, the Society is committed to Cornell University will focus on myeloma, funding six more SCOR grants over the an incurable cancer of the antibody- next three years, amounting to a total of producing plasma cells. The team will $67.5 million in team-based research. work to understand the genetic basis of this cancer, control the accumulation These grants are designed to bring together of malignant cells and prevent bone Marshall A. Lichtman, MD, Executive Vice President, Research programs that share a common research destruction caused by the myeloma. and Medical Programs focus and attack the same scientific problems. With scientists from different The SCOR at Dana-Farber Cancer disciplines working in concert, the research Institute will concentrate on developing community will have a better chance to curative therapies for acute and chronic develop cures and achieve significantly myelogenous leukemias by providing higher survival rates. ways to translate laboratory research into novel approaches for diagnosis and treatment.
www.leukemia-lymphoma.org 7 gthening
Marshall Lichtman, MD, congratulates SCOR awardees (l-r): James D. Griffin, MD, Dana-Farber Cancer Institute; Selina Chen-Kiang, PhD, Weill Medical College, Cornell University; Brian J. Druker, MD, Oregon Health Sciences University
The SCOR at Oregon Health Sciences Scientists from different University, in collaboration with scientists at disciplines working together the M.D. Anderson Cancer Center and the will have a better chance to University of California at Los Angeles, will “ focus on chronic myelogenous leukemia develop cures and achieve (CML) and a compound known as STI-571, higher survival rates. which has had remarkable success in putting CML patients into remission in recent clinical trials. This center will work to determine the causes of CML and how to best use STI-571 as a treatment. ” 8
Thanks to the Society’s research efforts, the survival rate for children with acute lymphocytic leukemia is 81%.
www.leukemia-lymphoma.org 9
Strengthening research— $200 million and counting
While the SCOR grants are the newest and largest additions to the Society’s research effort, more than $200 million in grants have been awarded since the Society’s founding. In fact, research expenditures have more than doubled over the last three years, to $32 million in 2000, in support of broad-based studies targeted to increase cure rates.
The Career Development Program provides new ideas to the laboratory. To further funding for the most promising young translate gains in basic knowledge to an scientists. Currently, the Society supports increase in cure rates, the Society also 129 Fellows and 153 Special (advanced) initiated a variation of its Scholar Program, Fellows who work with outstanding senior known as Scholars in Clinical Research. scientists to uncover the mysteries of the Since it began three years ago, this (l-r) Peter J. Quesenberry, MD; W. Stratford May, Jr., MD, PhD; genes, molecules, and aberrant cell systems program has funded 13 scientists. Marshall A. Lichtman, MD that lead to blood-related cancers. Recognizing that the movement of basic In addition, 88 Scholars are supported by research to clinical application is the the Career Development Program. These final pathway to cures, the Society also scholars are young, independent scientists continues to expand its Translational bringing the most recent technologies and Research Program. The funding of research on STI - 571 in the treatment of chronic myelogenous leukemia (CML) is an example of the Society’s Research Funding Growth investment in new and promising 1996-2000 translational research. (in millions) In fiscal 2000, 131 Translational grants $32.0 were supported, offering potentially new approaches to chemotherapy, 25 $23.5 immunotherapy, and stem cell $20.0 transplantation. 20
$14.9 15 $11.6 10
5 1996 1997 1998 1999 2000 Research growthResearch 10
Extending our reach to patients and communities
Support, understanding and knowledge–they go a long way to help patients battle blood-related cancers. Nowhere are these qualities more concentrated and effective than in the Society’s expanding array of patient and community service programs.
From conducting Family Support Groups Through a collaboration with the National to helping children make a smooth Coalition for Cancer Survivorship, and transition from treatment back to school, supported by an educational grant from the Society is deeply committed to reaching Ortho Biotech, the Society offers “Cancer: every patient and family with services that Keys to Survivorship,” a seminar providing Hildy Dillon (standing), Senior Director, Information Resource Center; improve their lives. empowering information and tools. Tammi Haber, Senior Specialist, Participants learn about communicating Health Care Navigation In 2000, for example, the Society’s effectively with healthcare providers, Information Resource Center strategies for self-empowerment and (1-800-955-4572) connected more than self-care, obtaining and collecting health 35,000 patients, caregivers and healthcare insurance benefits, and employment professionals to the IRC’s skilled nurses rights issues. and social workers. The IRC staff provides timely information and referrals, including A new educational symposium also aimed data on diagnoses, treatment options and at assisting patients is “Improving the clinical trials, as well as guidance on Chemotherapy Experience.” Supported by second opinions and counseling. Amgen, Inc., ICE is designed to help chemotherapy patients help themselves For the newly diagnosed patient, First physically and emotionally through the Connection is a lifeline to a trained challenge of treatment. peer who understands the feelings and needs first-hand. In 2000, more than 2,200 individuals took advantage of this service, a figure that is expected to increase substantially. Extendi
www.leukemia-lymphoma.org our 11
David G. Poplack, MD, Chairman, Patient Services Committee; Robin Kornhaber, Vice President, Patient Services
The Society is deeply committed to reaching “ every patient and family with services that improve their lives. ”
How we help
• By providing a targeted series of psychosocial and practical services ng • By supporting patients, from diagnosis through treatment and recovery reach 12
Increasing our influence through advocacy
With almost 3,000 volunteers, the Society’s Advocates Network is a powerful voice on behalf of patients, speaking out to legislators and other government leaders on such issues as medical research funding, insurance coverage and access to care.
As a result, many Members of Congress Cancer Leadership Council, One Voice have become engaged in Society programs Against Cancer and The Independent and have gained a greater appreciation of Sector, the Society exerts a stronger the Society’s goals and the role they can influence on issues of common interest. play in achieving them. (l-r) Frank T. Short, Chairman, Public Policy Committee; George Dahlman, Looking ahead, the Society’s Public Policy Vice President, Public Policy After several years of legislative appeals office in Washington has been strengthened by Society advocates, President Clinton to help volunteers keep up with legislative announced on June 7 that Medicare would developments and facilitate swift and begin covering the routine care costs of targeted action. The Society’s web site and clinical trials, including meals, beds and its Legislative Action Center are part of nursing services. this effort. New recruitment materials and issue briefs, a stronger training curriculum With the helpful prodding of Society and a broader policy agenda have also advocates, the National Cancer Institute been designed to engage and mobilize Legislators and initiated a Progress Review Group on volunteer-advocates. blood-related cancers, which includes government officials are Society members, to help look for “ gaining a greater promising new research opportunities appreciation of their role that the NCI could support.
in helping the Society Meanwhile, the Society continues to forge achieve its goals. alliances with various groups in order to strengthen its hand with policymakers. As ” part of the National Health Council, the
President Clinton recognizes Leukemia and Lymphoma Awareness Month (September) in the Oval Office with Society President and CEO Dwayne Howell and several young patients.
www.leukemia-lymphoma.org 13
How you can help
• Join the Society’s Advocates Network • Learn about legislative issues affecting patients • Help speak out for patients and their families • Keep up with developments on Capitol Hill • Respond to "calls-to-action" by contacting legislators and expressing your concern about important issues 14
Growing o reven Growing our revenue base
Cures can be found only with more research. More research can take place only with more revenue. And so, the Society has been relentlessly growing its revenue base, which increased by 24% in 2000.
Through Team In Training®, the Society’s Garden Restaurants, “Pennies for Patients” largest fundraising effort, volunteers raise and “Hop for Leukemia,” school children funds running, walking, cycling and raised nearly $9 million in fiscal 2000, swimming, as they train to participate in while reaping the personal reward of prestigious endurance events. helping people.
The Light The Night® Walk is another Meanwhile, major gifts from individuals, Harry Pearce, Vice Chairman of dynamic fundraising and awareness corporations and foundations continue to General Motors, launched a personal crusade to raise millions of dollars for campaign. In its second year as a national be a vital source of support. Harry Pearce, research, including a $1.5 million event, Light The Night was held at over Vice Chairman of General Motors, is taking grant from GM for the SCOR program. 170 sites in September 2000, up from 100 his own successful battle with leukemia in 1999. Result: revenues nearly doubled. from the hospital to the boardroom. Not only is GM leading the way with a $1.5 Other grassroots events that are growing million grant for the SCOR program, but significantly include the School & YouthTM Mr. Pearce is launching a personal crusade Programs. Through such programs as to raise millions of new research dollars “Pasta for Pennies” sponsored by Olive with his Journey of Hope Major Gift
www.leukemia-lymphoma.org 15
How you can help
• Make a personal gift to the Society • Become a participant and enlist your business or employer in Light The Night® Walk • Take on the challenge of Team In Training® • Volunteer for fundraising events through your local Society chapter ur • Include the Society in your will • Make a donation in the name of someone you love ue
Net Revenue Growth 1996-2000 (in millions) Campaign. Also joining the crusade are $133.4 Tom and Sandy Bertelsen of California. The 120 Bertelsens are supporting a SCOR project led by Dr. Brian Druker, which focuses on finding $107.2 100 cures for CML. $83.8 80
$58.2 60 $49.8
40
20 1996 1997 1998 1999 2000 Revenue growthRevenue
(l-r) David S. Dimling, Chairman, Fundraising Committee; Richard J. Geswell, Senior Vice President, Revenue Development 16
How you can help
• Participate in one of the Society’s major events through your local chapter • Make a contribution when you receive direct response fundraising materials • Speak out about the good work of the Society to your friends and neighbors
www.leukemia-lymphoma.org 17
Increasing public awareness
The Leukemia & Lymphoma Society uses a number of marketing and communications tools to increase public awareness about the organization’s mission, and to help raise funds.
In the public relations arena, the Society Media events also help spread the word is contacting leading medical and scientific to millions of people while raising funds. writers and reporters about the volume Annual events include syndicated talk and nature of Society-funded research and show host Rush Limbaugh’s annual radio patient services. The focus in 2000 is on campaign, and the “Chase to the Cure” the new Specialized Center of Research television special, broadcast in New York (SCOR) Program, which generates interest on WPIX-TV and sponsored by Chase as significant news and builds a foundation Manhattan Bank. In Fall 2000, new public for ongoing media relations. service announcements featuring celebrity Cindy Crawford, a trustee Cindy Crawford, a trustee of the New of the New York City Meanwhile, the Society reached more York City Chapter, also began hitting the chapter, speaks out in the Society’s public service than 18 million households and small airwaves around the country. advertising campaign. businesses through a campaign of direct mail, telemarketing, neighborhood drives Advertising and promotions supporting and e-marketing. In addition to raising major Society events also go a long way funds, these campaigns inform the to increase participation and enhance public about blood-related cancers and awareness. Ads in national magazines Society programs. helped to draw nearly 30,000 participants for Team In Training®, and public service announcements on TV reached millions of viewers. Light The Night® Walk drew nearly 50,000 participants, and millions of people to the Society’s Light The Night Walk message, thanks to related magazine and internet ads and web site hits.
(l-r) Norbert J. Sieber, Chairman, Marketing and Communications Committee; Robert K. Wehrmann, Senior Vice President, Marketing and Strategy Development 18
Advancing our mission through volunteer-staff partnership
The dynamic partnership between volunteers and staff is a critical element in advancing the Society’s mission. Volunteers—from the national board and local trustees, to scientists contributing their time and talents to identify the most promising research, to local event organizers and participants—bring passion and enthusiasm in all they do.
Without volunteers, the Society’s relentless introduced to challenge trustees to make Staff members of the Fairfield pursuit of cures for blood-related cancers the highest impact possible—in accessing County (Connecticut) Chapter wrap would be stopped cold. Meanwhile, the resources in their communities, advancing up a meeting. staff provides the support and technical the Society’s mission, and ensuring the expertise to volunteers, which result in ongoing health and productivity of the high-quality and productive programs organization. and events. Only with high-impact boards, working in At all 58 chapters, volunteer trustees join conjunction with staff, can the job of staff to provide the leadership, strategic attracting, training and mobilizing tens of planning, community organizing and thousands of volunteers be accomplished. recruitment skills to achieve the Society’s These are the people who organize events, goals. This past year, new guidelines were answer phones, support healthcare
How you can help
• Volunteer at your local Society chapter • Help to recruit other volunteers • Recommend community leaders to serve as Ad chapter trustees • Participate in local programs and events our missi
www.leukemia-lymphoma.org 19
(l-r) Paul Weiss, Senior Vice President, Chapter Development; Lynn C. Hoover, Chairman, Chapter Development Committee
professionals in patient service programs, advocate for research funding to state and local officials, and reach out to the The volunteer-staff community in innumerable ways. partnership fuels the The volunteer-staff partnership fuels the “Society’s mission to find Society’s mission, enabling everyone to cures for all blood- work better and smarter to advance the related cancers. Society’s relentless quest to find cures for all blood-related cancers. ”
vancing on 20
Building a stronger team for the future People who work for The Leukemia & Lymphoma Society know they are making a difference in the battle against blood-related cancers. It’s not just a job, but a passionate commitment.
To make sure everyone is working as enable regional and chapter leaders, key effectively and efficiently as possible, staff and volunteers to learn, share ideas, the Society continues to strengthen its and reward excellence, so they can meet infrastructure and foster a team-based their respective challenges refreshed environment that motivates both staff and motivated. and volunteers alike. The Internet opportunity This year’s Home Office move to White (l-r) Donald H. Salsbery, Plains, New York, for instance, helps to Nothing, however, will be a greater team- Chairman, Administration Committee; Cynthia Gardner meet those objectives by optimizing office building tool than the Internet. Already in Cross, Vice President, space while minimizing costs, enhancing 2000, more than a million people contacted Administration recruitment efforts and centralizing the Society through its web site, a number on-site training—so that staffers and that’s expected to triple in the next year. volunteers from around the country can reap the benefit of face-to-face interactions With new Internet capabilities coming with colleagues. on line in early 2001, the Society’s web site will be an even more dynamic Training, networking and recognition resource, reaching, engaging and delivering programs are also key components of individualized services to millions of building a stronger team. The Annual people immediately—any time, anywhere. Leadership Conference and the Annual For patients, their families, volunteers, Professional Conference, for example, healthcare professionals, donors and others, the site will offer high levels of interaction, customization, rich content and links to Buildingchapters and other relevanta sites.
www.leukemia-lymphoma.orgstronger 21
(l-r) John Walter, Senior Vice President, Finance and Information Technology; William S. Lear, Chairman, Internet Committee
When a visitor provides an e-mail address For chapter offices, these new capabilities and a profile of interest, the Society will be will provide a centralized, “turnkey” able to offer that visitor an individualized infrastructure. With a simple PC and “home page” for receiving the latest Internet access, chapters will be fully information, program updates and clinical connected to the rest of the organization, news that match his or her specific needs. yet be able to tailor web site information This capability will empower patients, on their activities and events. for example, with the latest medical information and guidance to ensure the best treatment for their disease.
The visitor’s home page will also be able Andrew E. Nolan, Chairman, to archive pertinent video presentations, Finance Committee teleconferences and other educational sessions. Additionally, the web site will offer online registration and instruction, and direct support to those who want to John Walter, Senior Vice President, participate in advocacy, fundraising and Finance and Information Technology other programs that strengthen the Society’s mission.
How you can help
• Find out about career opportunities at the Society • Get comfortable with the Internet • Promote the use of information technology • Explore the Society’s website and refer teamothers to it Research grants—SCOR and Career Development Program
Specialized Center of Research 1 James A. DeCaprio, MD – 1997 Sally Kornbluth, PhD – 1998 Ruibao Ren, MD, PhD – 1998 Da n a - Fa r ber Cancer Institute Duke Uni v e rsity Medical Center Brandeis Uni v e rs i t y Selina Chen-Kiang, PhD – 200 0 Weill Medical College of Cornell Uni v e rs i t y James DeGregori, PhD – 200 0 David Lambright, PhD – 1998 Erle S. Robertson, PhD – 1999 Uni v e rsity of Colorado Health Uni v e rsity of Massachusetts Medical Center Uni v e rsity of Michi g a n Brian J. Druker, MD – 2000 2 Sc i e n c es Center Oregon Health Sciences Uni v e rs i t y Hyam I. Levitsky, MD – 1997 Barrett J. Rollins, MD, PhD – 1995 Laurence C. Eisenlohr, VMD, PhD – 1999 Johns Hopkins Uni v e rsity School of Medicine Da n a - Fa r ber Cancer Institute James D. Griffin, MD - 200 0 Thomas Jefferson Uni v e rs i t y 6 Da n a - Fa r ber Cancer Institute Daniel I. Lew, PhD – 200 0 David Ron, MD – 1996 Mark E. Ewen, PhD – 1997 Duke Uni v e rsity Medical Center New York Uni v e rsity Medical Center Career Development Program — Da n a - Fa r ber Cancer Institute Sc h o l a r s Jonathan D. Licht, MD – 1995 Paul Rothman, MD – 1995 Carolyn A. Felix, MD – 1996 Mount Sinai School of Medicine Columbia Uni v e rs i t y Paul J. Anderson, MD – 1995 Ch i l d r e n ’s Hospital of Philadelphia Brigham and Wom e n ’s Hosp i t a l Paul Lieberman, PhD – 1997 Moshe J. Sadofsky, MD, PhD – 1999 Alan Pat r i ck Fields, PhD – 1995 The Wistar Institute Me d i cal College of Georgia Donald E. Ayer, PhD – 1998 Uni v e rsity of Texas, Galvest o n Uni v e rsity of Uta h Hsiou-Chi Liou, PhD – 200 0 Kathleen M. Sakamoto, MD – 1998 Susan L. Forsburg, PhD – 1997 Weill Medical College of Cornell Uni v e rs i t y Uni v e rsity of California, Los Angeles Ravi Basavappa, PhD – 1999 Salk Institute for Biological Studies 4 Uni v e rsity of Roches t e r Ri chard M. Longnecker, PhD – 1995 Charles L. Sawyers, MD – 1995 Alan D. Friedman, MD – 1998 No r t h w es t e rn Uni v e rsity School of Medicine Uni v e rsity of California, Los Angeles Tim o t hy W. Behrens, MD – 1997 Johns Hopkins Uni v e rsity School of Medicine Uni v e rsity of Minneso t a Kun Ping Lu, MD, PhD – 1998 Christian W. Schindler, MD, PhD – 1996 Xiang-Dong Fu, PhD – 1997 Beth Israel Deaconess Medical Center Columbia Uni v e rs i t y Mark Boothby, MD, PhD - 1995 Uni v e rsity of California, San Diego Vanderbilt Uni v e rsity School of Medicine Ri chard S. Mann, PhD – 1997 Mark Schlisel, MD, PhD – 1996 Peter M. Glazer, MD, PhD – 1996 Columbia Uni v e rsity Health Sciences Uni v e rsity of California, Berkeley Katherine Borden, PhD – 200 0 Yale Uni v e rs i t y Mount Sinai School of Medicine Garry P. Nolan, PhD – 1995 Ed ward W. Scott, PhD – 1998 Mi chael J. Grusby, PhD – 1997 Stanford Uni v e rsity School of Medicine Uni v e rsity of Pen n s y l v a n i a Emery H. Bresnick, PhD – 1997 Ha rvard School of Public Health Uni v e rsity of Wisconsin Medical Scho o l Giuseppina Nucifora, PhD – 1998 David C. Seldin, PhD – 200 0 Wendy L. Havran, PhD – 1996 Lo yola Uni v e rsity of Chicag o Boston Medical Center Stephen Buratowski, PhD – 1999 The Scripps Rese a r ch Institute Ha rvard Medical Scho o l Matthew J. O’Connell, PhD – 200 0 Margaret A. Shipp, MD – 1995 Philip W. Hinds, PhD – 1995 Peter MacCallum Cancer Institute Da n a - Fa r ber Cancer Institute Frederic D. Bushman, PhD – 1996 Ha rvard Medical Scho o l Salk Institute for Biological Studies Marjorie Oettinger, PhD – 1996 Ramesh A. Shivdasani, MD, PhD – 200 0 Jae Jung, PhD – 200 0 Ma s s a chusetts General Hosp i t a l Da n a - Fa r ber Cancer Institute Don Chen, PhD – 200 0 Ha rvard Medical Scho o l 5 Uni v e rsity of Massachusetts Medical Scho o l Pier Paolo Pandolfi, MD, PhD – 1997 Gerald Siu, PhD – 200 0 An t h o ny N. Imbalzano, PhD – 1999 Me m o rial Sloan-Ket t e ring Cancer Center Columbia Uni v e rsity Health Sciences Genhong Cheng, PhD – 200 0 Uni v e rsity of Massachusetts Medical Center Uni v e rsity of California, Los Angeles Susan M. Parkhurst, PhD – 1995 Tomasz Skorski, MD, PhD – 200 0 Y. Tony Ip, PhD – 1996 Fred Hutchinson Cancer Rese a r ch Center Temple Uni v e rs i t y Jonathan Chernoff, MD, PhD – 1997 Uni v e rsity of Massachusetts Medical Center Fox Chase Cancer Center Waren S. Pear, MD, PhD – 1998 Andreas Strasser, PhD – 1997 Mark P. Kamps, PhD – 1997 Uni v e rsity of Pen n s y l v a n i a The Walter and Eliza Hall Institute K. M. Coggeshall, PhD – 1998 Uni v e rsity of California, San Diego Oklahoma Medical Rese a r ch Fou n d a t i o n David S. Pellman, PhD – 200 0 Mi chel Streuli, PhD – 1997 Nigel Killeen, PhD – 200 0 Da n a - Fa r ber Cancer Institute Da n a - Fa r ber Cancer Institute Alan D. D’Andrea, MD – 1995 Uni v e rsity of California, San Fra n c i s c o Da n a - Fa r ber Cancer Institute B. Franklin Pugh, PhD – 1996 Charles D. Surh, PhD – 1999 Mi chael Koelle, PhD – 1999 Pennsylvania State Uni v e rs i t y The Scripps Rese a r ch Institute George O. Daley, MD, PhD – 1999 3 Yale Uni v e rs i t y Whitehead Institute for Biological Rese a r ch David J. Rawlings, MD – 1999 Guillermo E. Taccioli, PhD – 1998 Uni v e rsity of California, Los Angeles Boston Uni v e rsity School of Medicine
1 The Special Center of Research Grant Program is 4 Dr. Longnecker is supported in part by generous 6 Dr. Ron, a Stephen Birnbaum Scholar, is supported in part by a generous gift from General gifts to the Society from the Berner Charitable & funded by a generous gift to the Society from Mortors Foundation. Scholarship Foundation and the Helen V. Brach The Stephen Birnbaum Foundation. Foundation. 2 The Special Center of Research Grant of Dr. Brian J. Druker is funded in part by a generous gift from 5 Dr. Pandolfi is supported by a generous gift to The Bertelsen Family. the Society from The Reichman Memorial and The Altshul Foundation. 3 Dr. Daley, a Stephen Birnbaum Scholar, is funded by a generous gift to the Society from The Stephen Birnbaum Foundation. Tse-Hua Tan, PhD – 1996 St e ven D. Gore, MD – 1998 Daniel Denis Billadeau, PhD – 1999 Zonghan Dai, PhD – 1997 Baylor Uni v e rsity College of Medicine Johns Hopkins Uni v e rsity School of Medicine Ma yo Clinic Uni v e rsity of Colorado
Dimitris Thanos, PhD – 200 0 Mary Joan Laughlin, MD – 1998 Stacy W. Blain, PhD – 1999 12 Beatrice D. Darimont, PhD – 1999 Columbia Uni v e rs i t y Case West e rn Rese rve Uni v e rs i t y Me m o rial Sloan-Ket t e ring Cancer Center Uni v e rsity of California, San Fra n c i s c o
Sheila M. Thomas, PhD – 1999 Jane L. Liesveld, MD – 1998 Peter Blume-Jensen, MD, PhD – 1998 Charles J. DiComo, PhD – 200 0 Beth Israel Deaconess Medical Center Uni v e rsity of Roches t e r The Salk Institute for Biological Studies for Me m o rial Sloan-Ket t e ring Cancer Center Bi o l o g i cal Studies Ri chard A. Van Etten, MD, PhD – 1998 Dana C. Mathews, MD – 1999 Ab by F. Dernburg, PhD – 1999 13 Ha rvard Medical Scho o l Fred Hutchinson Cancer Rese a r ch Center Mi chael Boddy, PhD – 200 0 Stanford Uni v e rsity School of Medicine The Scripps Rese a r ch Institute David L. Van Vactor, PhD – 200 0 Nikhil C. Munshi, MD – 1998 Ha n - Fei Ding, MD, PhD – 1998 Ha rvard Medical Scho o l Uni v e rsity of Arkansas for Medical Sciences Aleksey Bortvin, MD, PhD – 1999 Da n a - Fa r ber Cancer Institute Whitehead Institute David L. Vaux, MD, PhD – 1999 Robert J. Soiffer, MD – 1999 Mensur Dlakic, PhD – 200 0 The Walter and Eliza Hall Institute Da n a - Fa r ber Cancer Institute Julie A. Brill, PhD – 1997 Uni v e rsity of Michi g a n Stanford Uni v e rsity School of Medicine Catherine Verfaillie, MD – 1995 Edmund K. Waller, MD, PhD – 1998 Ri ck A. Fin ch, PhD – 1998 Uni v e rsity of Minneso t a Em o ry Uni v e rs i t y Grant W. Brown, PhD – 1998 Yale Uni v e rs i t y Johns Hopkins Uni v e rsity School of Medicine Jane Y. Wu, PhD – 1998 7 Christopher Walsh, MD, PhD – 200 0 Claire Francastel, PhD – 200 0 Washington Uni v e rs i t y Uni v e rsity of North Carolina, Chapel Hill Mary E. Bryk, PhD – 1998 Fred Hutchinson Cancer Rese a r ch Center Ha rvard Medical Scho o l Tim J. Yen, PhD – 1995 Career Development Program — David A. Fruman, PhD – 1998 Fox Chase Cancer Center Special Fel l o w s Donald Andrew Burden, PhD – 1998 Beth Israel Deaconess Medical Center Vanderbilt Uni v e rs i t y Kyoko Yokomori, PhD – 200 0 Ricardo C.T. Aguiar, MD, PhD – 1999 Hironori Funabiki, PhD – 1999 Uni v e rsity of California, Irvi n e Da n a - Fa r ber Cancer Institute Fernando Casares, PhD – 200 0 Uni v e rsity of California, San Fra n c i s c o Columbia Uni v e rs i t y Faith M. Young, PhD – 1998 Nicole Schreiber Agus, PhD – 1997 Guangxia Gao, PhD – 200 0 Uni v e rsity of Roches t e r Al bert Einstein College of Medicine Lucio H. Castilla, PhD – 1999 Columbia Uni v e rsity Health Sciences National Institutes of Health Dong-Er Zhang, PhD – 1998 Ashok Aiyar, PhD – 1999 Irene Garcia-Higuera, PhD – 200 0 The Scripps Rese a r ch Institute Uni v e rsity of Wisconsin, Madison Ch i n g -Ye Chen, PhD – 1999 Da n a - Fa r ber Cancer Institute Uni v e rsity of California, San Diego Liang Zhu, MD, PhD – 1999 S. Munir Alam, PhD – 1998 Paul A. Garrity, PhD – 1997 Al bert Einstein College of Medicine The Scripps Rese a r ch Institute Po Chen, PhD – 200 0 Ma s s a chusetts Institute of Tech n o l o g y Uni v e rsity of Texas, Dallas Yuan Zhuang, PhD – 1998 Edwin P. Alyea, MD – 1998 Stefan Gaubatz, PhD – 1999 Duke Uni v e rsity Medical Center Da n a - Fa r ber Cancer Institute Sim-Bee Cheng, PhD – 1997 Da n a - Fa r ber Cancer Institute The Scripps Rese a r ch Institute Career Development Program — Lee Bardwell, PhD – 1997 Scott Goode, PhD – 1997 Scholars in Clinical Res e a r c h Uni v e rsity of California, Berkeley Margaret Mary Chou, PhD – 1997 Baylor Uni v e rsity College of Medicine Uni v e rsity of Pen n s y l v a n i a Robert Brodsky, MD – 200 0 Christopher Thomas Beh, PhD – 1999 Atan Gross, PhD – 1999 Johns Hopkins Uni v e rsity School of Medicine Uni v e rsity of California, Berkeley Chang Y. Chung, PhD – 200 0 Da n a - Fa r ber Cancer Institute Uni v e rsity of California, San Diego Ri chard K. Burt, MD – 1998 8 Robert J. Benschop, PhD – 1998 Thomas M. Guadagno, PhD – 1998 No r t h w es t e rn Uni v e rs i t y National Jewish Medical & Rese a r ch Center Yolonda L. Colson, MD, PhD – 1997 Stanford Uni v e rsity College of Medicine Da n a - Fa r ber Cancer Institute Jorge Cortes, MD – 200 0 Fred Bertrand, PhD – 1999 10 Mounou Hahn, PhD – 1998 Uni v e rsity of Texas, Houston Uni v e rsity of Minneso t a Barbara Conradt, PhD – 1997 Uni v e rsity of California, San Fra n c i s c o Max Planck Institute Glenn Dranoff, MD – 200 0 An j a - Katrin Bielinsky, PhD – 1999 11 Hisashi Harada, PhD – 1998 Da n a - Fa r ber Cancer Institute Brown Uni v e rs i t y Crislyn D’Souza-Scho r e y, PhD – 1997 Da n a - Fa r ber Cancer Institute Washington Uni v e rs i t y Tim o t hy Jon Ernst, MD – 1998 9 David Bilder, PhD – 200 0 Hanno Hock, PhD – 1999 Boston Uni v e rsity School of Medicine Ha rvard Medical Scho o l Ch i l d r e n ’s Hospital Bost o n
7 Dr. Wu is supported by a generous gift to 10 Dr. Bertrand is supported by a generous gift to 12 Dr. Blain is supported by a generous gift from 13 Dr. Dernberg is supported by a generous gift to the Society from the Mary & Robert Bronstein the Society from The Chris P. Tkalcevic Foundation. Drs. Emile and Vivian Sandler in honor of Zvi Fuchs the Society from Pete Harman. Memorial Endowment Fund. of the Sloan-Kettering Radio/Oncology Department. 11 Dr. Bielinsky is funded by a generous gift to the 8 Dr. Burt is supported in part by generous gifts Society from Leslie Elliot Krause, Esq. to the Society from The Coleman Foundation, The Grant Healthcare Foundation, and the Dr. Scholl Foundation.
9 Dr. Ernst, a Stephen Birnbaum Scholar for Clinical Research, is funded by a generous gift to the Society from The Stephen Birnbaum Foundation. Research grants—Career Development Program
Linda S. Huang, PhD – 1999 Evert Kroon, PhD – 1999 Christopher L. North, PhD – 1999 Anne Satterthwaite, PhD – 1998 19 Uni v e rsity of California, San Fra n c i s c o Cl i n i cal Rese a r ch Institute of Montreal Ha rvard Medical Scho o l HHMI, Uni v e rsity of California, Los Angeles
David Ching Siang Huang, MD – 1998 Roland P.S. Kwok, PhD – 1997 Masaki Okano, PhD – 1999 Brian Schaefer, PhD – 200 0 The Walter and Eliza Hall Institute Uni v e rsity of Michi g a n Ma s s a chusetts General Hosp i t a l National Jewish Medical & Rese a r ch Center
Paul Hughes, D Phil – 1997 Jongbum Kwon, PhD – 1999 Barbara Dell Page, PhD – 1997 Clemens A. Schmitt, PhD – 200 0 The Scripps Rese a r ch Institute Ma s s a chusetts General Hosp i t a l Fred Hutchinson Cancer Rese a r ch Center Cold Spring Harbor Labor a t o ry
Jorge A. I˜niguez-Lluhi, PhD – 1997 Mi chael Lagunoff, PhD – 1999 Manolis Pasparakis, PhD – 200 0 Brenda A. Schulman, PhD – 200 0 Uni v e rsity of California, San Fra n c i s c o Uni v e rsity of California, San Fra n c i s c o Uni v e rsity of Cologne Me m o rial Sloan-Ket t e ring Cancer Center
14 Br yan A. Irving, PhD – 1999 Siyuan Le, PhD – 1999 Jonathan M. Passner, PhD – 1999 Jo a chim L. Schultze, MD – 1998 Uni v e rsity of California, San Fra n c i s c o Johns Hopkins Uni v e rsity School of Medicine Mount Sinai School of Medicine Da n a - Fa r ber Cancer Institute
16 Feng Jiang, PhD – 1997 Sang Eun Lee, PhD – 200 0 Debananda Pati, PhD – 1999 Jae Hong Seol, PhD – 200 0 Me m o rial Sloan-Ket t e ring Cancer Center Brandeis Uni v e rs i t y Texas Children’s Cancer Center Ca l i f o rnia Institute of Tech n o l o g y
Jin Jiang, PhD – 1998 Qi n tang Li, PhD – 200 0 Garth Patterson, PhD – 1997 Thomas L. Serano, PhD – 200 0 Uni v e rsity of Texas, Galvest o n The Salk Institute for Biological Studies Ru t g e rs Uni v e rs i t y Uni v e rsity of California, Berkeley
Claudio Joazeiro, PhD – 200 0 Qing Liu, PhD – 200 0 Yuri Pek a r s ky, PhD – 200 0 Kei - i chi Shabahara, PhD – 200 0 The Salk Institute for Biological Studies Brigham and Wom e n ’s Hosp i t a l Thomas Jefferson Uni v e rs i t y Cold Spring Harbor Labor a t o ry
17 Steffen Jung, PhD – 1999 Sh o u chun Liu, PhD – 200 0 P. Shannon Pendergrast, PhD – 1998 Caroline E. Shamu, PhD – 1998 Skirball Institute The Scripps Rese a r ch Institute Cold Spring Harbor Labor a t o ry Ha rvard Medical Scho o l
Kenneth B. Kaplan, PhD – 1997 Christina Lopez-Rodriguez, PhD – 200 0 Gabriela C. Per e z - A l varado, PhD – 200 0 Virginia Smith Shapiro, PhD – 1998 Ma s s a chusetts Institute of Tech n o l o g y Ha rvard Medical Scho o l The Scripps Rese a r ch Institute HHMI, Uni v e rsity of California, San Fra n c i s c o
Mark H. Kaplan, PhD – 1997 Jon R. Lorsch, PhD – 1998 Joel L. Pomerantz, PhD – 200 0 Robert Joseph Sheaff, PhD – 1997 Indiana Uni v e rs i t y Stanford Uni v e rsity School of Medicine Ca l i f o rnia Institute of Tech n o l o g y Uni v e rsity of Minneso t a
Barbara L. Kee, PhD – 1998 Hong Luo, PhD – 1997 Antonio A. Postigo, MD, PhD – 1999 Wu-Cheng Shen, PhD – 1998 Uni v e rsity of California, San Diego Ma s s a chusetts General Hosp i t a l Washington Uni v e rsity Uni v e rsity of Massachusetts Medical Center
Sepideh Khorasanizadeh, PhD – 1998 Xu Luo, PhD – 200 0 Pascal Preker, PhD – 200 0 Hyun Suk Shim, PhD – 1998 HHMI, Uni v e rsity of Maryl a n d Uni v e rsity of Texas, Dallas Uni v e rsity of California, San Fra n c i s c o Johns Hopkins Uni v e rsity School of Medicine
Un kyu Kim, PhD – 1998 Wallace Marshall, PhD – 200 0 Louise E. Purton, PhD – 1999 Protul A. Shrikant, PhD – 200 0 The Rockefeller Uni v e rs i t y Yale Uni v e rsity School of Medicine Fred Hutchinson Cancer Rese a r ch Center Roswell Park Cancer Center
Jae Bum Kim, PhD – 1999 Fabio Martelli, PhD – 1998 Vikram Rao, PhD – 1999 Julia Sidorova, PhD – 1999 Ma s s a chusetts Institute of Tech n o l o g y Da n a - Fa r ber Cancer Institute Ha rvard Medical Scho o l Fred Hutchinson Cancer Rese a r ch Center
Keiji Kimura, PhD – 1997 Grant A. McArthur, PhD – 1998 Alo Ray, PhD – 1999 David A. Sinclair, PhD – 1999 Cold Spring Harbor Labor a t o ry Peter MacCullum Cancer Institute Cleveland Clinic Fou n d a t i o n Ma s s a chusetts Institute of Tech n o l o g y
David T. Kirkpatrick, PhD – 1998 St e ven B. McMahon, PhD – 1998 Rachel E. Rempel, PhD – 1997 Maria S. Soengas, PhD – 1999 Uni v e rsity of North Carolina, Chapel Hill Princeton Uni v e rs i t y Duke Uni v e rsity Medical Center Cold Spring Harbor Labor a t o ry
Ri chard Klinghoffer, PhD – 200 0 David S. McNabb, PhD – 1997 Rolf Renne, PhD – 1997 Lisa N. Spirio, PhD – 1998 Fred Hutchinson Cancer Rese a r ch Center Ma s s a chusetts Institute of Tech n o l o g y Case West e rn Rese rve Uni v e rs i t y Whitehead Institute
An t h o ny J. Kol e s ke, PhD – 1997 Raul Mendez, PhD – 1998 Ni cholas Rhind, PhD – 1999 Charles H. Spruck III, PhD – 1999 Yale Uni v e rs i t y Uni v e rsity of Massachusetts Medical Center The Scripps Rese a r ch Institute The Scripps Rese a r ch Institute
15 18 Keith J. Kozminski, PhD – 1999 John Nip, PhD – 1998 Christine Richardson, PhD – 1999 Sr i n i vasa M. Srinivasula, PhD – 200 0 Uni v e rsity of California, Berkeley Vanderbilt Uni v e rsity School of Medicine Me m o rial Sloan-Ket t e ring Cancer Center Kimmel Cancer Center
14 Dr. Irving is supported by a generous gift to the 16 Dr. Lee is supported by a generous gift to the 17 Dr. Pendergrast is supported by a generous 19 Dr. Satterthwaite is supported in part by a Society from the Board of Trustees and Staff, Society from The Hildegarde D. Becher Foundation. gift to the Society from the Jane Elissa/Charlotte generous gift to the Society from Parents Against Northern California Chapter. Meyers Fund. Leukemia.
15 Dr. Kozminski is supported in part by a generous 18 Dr. Richardson is supported by a generous gift to gift to the Society from the Wayne & Gladys Valley the Society from the Vrushali Ranadave Fel l o w s h i p Foundation. Endowment Fun d . William L. Stanford, PhD – 1999 20 P. Renee Yew, PhD – 1997 Jiunn-Liang Chen, PhD – 200 0 Andrew J. Gale, PhD – 1997 Lunenfeld Rese a r ch Institute Uni v e rsity of Texas, San Antonio Johns Hopkins Uni v e rsity School of Medicine The Scripps Rese a r ch Institute
David Steger, PhD – 200 0 Ebrahim Zandi, PhD – 1998 Ai yang Cheng, PhD – 200 0 Fra n ck Gesbert, PhD – 200 0 Uni v e rsity of California, San Fra n c i s c o Uni v e rsity of Southern Californi a Yale Uni v e rsity School of Medicine Da n a - Fa r ber Cancer Institute
Ren a ta Stripecke, PhD – 1999 Martin Peter Zeidler, PhD – 1999 Ni cholas D. Chester, PhD – 1997 22 Indraneel Ghosh, PhD – 1999 Uni v e rsity of Southern Californi a Ha rvard Medical Scho o l Ha rvard Medical Scho o l Yale Uni v e rsity School of Medicine
Ma s a h i ko Sugita, MD – 1999 Ji a n ke Zhang, PhD – 1997 Tianhuai Chi, MD, PhD – 1997 Keow Lin Goh, PhD – 200 0 Brigham and Wom e n ’s Hosp i t a l Uni v e rsity of California, Berkeley HHMI, Stanford Uni v e rs i t y Ma s s a chusetts Institute of Tech n o l o g y
Susanne Szabo, PhD – 200 0 Career Development—Fel l o w s Penelope R. Chua, PhD – 1998 Felicia D. Goodrum, PhD – 1999 Ha rvard School of Public Health Uni v e rsity of California, Berkeley Princeton Uni v e rs i t y Nagi G. Ayad, PhD – 200 0 Takashi Tanaka, PhD – 200 0 Ha rvard Medical Scho o l Jason Conaty, PhD – 200 0 Vid ya Gopalakrishnan, PhD – 1997 Ha rvard School of Public Health Ha rvard Medical Scho o l Johns Hopkins Uni v e rsity School of Medicine Allison M. Baird, PhD – 1997 Amy H. Tang, PhD – 1998 Oregon Health Sciences Center Patricia D. Conrad, MD – 1999 Tim o t hy Charles Grammer, PhD – 1998 Uni v e rsity of California, Berkeley Ch i l d r e n ’s Hospital of Philadelphia Uni v e rsity of California, Berkeley Janna Bednenko, PhD – 1999 Eduardo Sergio Tro m b e t ta, PhD – 1998 The Scripps Rese a r ch Institute Laurence J.N. Cooper, MD, PhD – 1999 Emir Hadzic, PhD – 1997 Yale Uni v e rsity School of Medicine Fred Hutchinson Cancer Rese a r ch Center The Rockefeller Uni v e rs i t y Kamel Benlagha, PhD – 1999 Vernon J. Twom b l y, PhD – 1999 Princeton Uni v e rs i t y Andrew Cuddihy, PhD – 1999 Tim o t hy J. Haggerty, PhD – 1998 Ha rvard Medical Scho o l Lady Davis Institute for Medical Rese a r ch Johns Hopkins Uni v e rsity Medical Scho o l Ivan Borrello, MD – 1998 Jessica Kate Tyler, PhD – 1998 Johns Hopkins Uni v e rsity School of Medicine Sorab N. Dalal, PhD – 1997 Katayoon Hojjati-Emami, PhD – 1999 Uni v e rsity of California, San Diego Da n a - Fa r ber Cancer Institute Ca l i f o rnia Institute of Tech n o l o g y Christine E. Brown, PhD – 200 0 Hisse Martien Van Santen, PhD – 200 0 Pennsylvania State Uni v e rs i t y La x m i n a r ayana R. Devireddy, PhD – 1999 Nancy A. Hong, PhD – 1999 Ha rvard Medical Scho o l Uni v e rsity of Massachusetts Medical Center Uni v e rsity of California, San Fra n c i s c o Frank Bucholz, PhD – 1998 Jose A. Villadangos, PhD – 200 0 Uni v e rsity of California, Berkeley Fre d e r i ck A. Dick, PhD – 1999 Duncan Howie, PhD – 1999 The Walter and Eliza Hall Institute Ma s s a chusetts General Hosp i t a l Beth Israel Deaconess Medical Center Im awati Budihardjo, MD, PhD – 1998 Martin Villalba, PhD – 1999 HHMI, Uni v e rsity of Texas, Dallas Andrew Thomas Dudley, PhD – 1998 Yuchu Hsiung, PhD – 1997 La Jolla Institute for Allergy and Immunology Ha rvard Medical Scho o l The Scripps Rese a r ch Institute Elizabeth A. Burton, PhD – 200 0 Marie A. Vod i cka, PhD – 200 0 Duke Uni v e rsity Medical Center Dominik Duelli, PhD – 200 0 Xuejun Huang, PhD – 1999 Fred Hutchinson Cancer Rese a r ch Center Cold Spring Harbor Labor a t o ry Uni v e rsity of California, San Diego Scott L. Butler, PhD – 1999 Mi chael Wei n r e i ch, PhD – 1997 The Salk Institute for Biological Studies Charles L. Far n s worth, PhD – 1998 Kat hyjo Jackson, PhD – 200 0 Cold Spring Harbor Labor a t o ry Ha rvard Medical Scho o l Baylor College of Medicine Xi a o chun Cao, PhD – 200 0 Matthew D. Wel ch, PhD – 1997 Brigham and Wom e n ’s Hosp i t a l Adolfo Ferrando, PhD – 200 0 Eric Julien, PhD – 1999 Uni v e rsity of California, Berkeley Da n a - Fa r ber Cancer Institute Cold Spring Harbor Labor a t o ry Paul A. Carpenter, MD – 1999 John C. Williams, PhD – 1999 Fred Hutchinson Cancer Rese a r ch Center Monique Floer, PhD – 200 0 Janusz Kab a r owski, PhD – 1999 Columbia Uni v e rsity Health Sciences Me m o rial Sloan-Ket t e ring Cancer Center Uni v e rsity of California, Los Angeles Giulia Celli, PhD – 200 0 Scot A. Wolfe, PhD – 1999 The Rockefeller Uni v e rs i t y Elsa Flores, PhD – 200 0 Robert E. Kal e j ta, PhD – 1997 Ma s s a chusetts Institute of Tech n o l o g y Ma s s a chusetts Institute of Tech n o l o g y Princeton Uni v e rs i t y Raymond C. Chan, PhD – 1999 Louisa Wu, PhD – 1997 Uni v e rsity of California, Berkeley Ri chard Neil Freiman, PhD – 1999 Hu n g -Ying Kao, PhD – 1998 Me m o rial Sloan-Ket t e ring Cancer Center Uni v e rsity of California, Berkeley The Salk Institute for Biological Studies Feng Chen, PhD – 1999 21 Lili Yamasaki, PhD – 1997 HHMI, Stanford Uni v e rs i t y Christopher Fry, PhD – 200 0 Mark Kaplan, PhD – 200 0 Columbia Uni v e rsity Health Sciences Uni v e rsity of Massachusetts Medical Center Uni v e rsity of Wisconsin, Madison
20 Dr. Stanford is supported by a generous gift to 21 Dr. Chen is supported by a generous gift to the 22 Dr. Chester is supported by a generous gift to the the Society from The Karyn Glick Rese a r ch Fun d . Society from The Valley Foundation. Society from The Hildegarde D. Becher Fou n d a t i o n . Ann Kel l y, PhD – 200 0 Pei-Jung Lu, PhD – 1999 Hai Rao, PhD – 1998 Scott Tibbetts, PhD – 200 0 Am e ri can Red Cross Beth Israel Deaconess Medical Center Ca l i f o rnia Institute of Tech n o l o g y Washington Uni v e rsity School of Medicine
Brian Ken n e d y, PhD – 1997 Biao Luo, PhD – 1999 Karlyne M. Rei l l y, PhD – 1997 Mi chael Tomasson, MD – 1997 Ma s s a chusetts General Hosp i t a l Whitehead Institute Ha rvard Uni v e rs i t y Brigham and Wom e n ’s Hosp i t a l
Andrei V. Khokhlatche v, PhD – 1999 Bart Lutterbach, PhD – 1998 25 Stephanie Anne Richards, PhD – 1998 Susheela Tridandapani, PhD – 200 0 Ma s s a chusetts General Hosp i t a l Vanderbilt Uni v e rs i t y Ha rvard Medical Scho o l Ohio State Uni v e rs i t y
Chang H. Kim, PhD – 1999 23 Erik Martinez-Hackert, PhD – 1998 26 Celeste Jeanne Richardson, PhD – 1999 27 Chainarong Tunyaplin, PhD – 1997 Stanford Uni v e rs i t y HHMI, Columbia Uni v e rs i t y Ha rvard Medical Scho o l Columbia Uni v e rsity Health Sciences
Tae - H young Kim, PhD – 200 0 Lori F. Maxfield, PhD – 1998 Stephanie E. Rieder, PhD – 1999 Indira Unnikrishnan, PhD – 1999 Uni v e rsity of Pittsburgh School of Medicine Tufts Uni v e rsity School of Medicine The Scripps Rese a r ch Institute Tufts Uni v e rsity School of Medicine
Tatiana V. Kol e s n i kova, PhD – 1999 24 Catherine J. McMahan, PhD – 1998 Sh r i kesh Sachd e v, PhD – 1999 Kirsten K. Wal ker, PhD – 1997 Da n a - Fa r ber Cancer Institute Uni v e rsity of Was h i n g t o n Ludwig-Maximilians Uni v e rs i t y The Salk Institute for Biological Studies
Rhett Kovall, PhD – 200 0 Taha Merghoub, PhD – 1999 Thomas Schlindler, Dr Rer Nat – 200 0 Pablo Wappner, PhD – 1997 Columbia Uni v e rsity Health Sciences Me m o rial Sloan-Ket t e ring Cancer Center The Rockefeller Uni v e rs i t y Weizmann Institute of Science
Yuen Yu Amy Lam, PhD – 1998 Nadeem Moghal, PhD – 1998 Catherine A. Schnabel, PhD – 1998 28 Tetsuro Watabe, PhD – 1998 Johns Hopkins Uni v e rsity School of Medicine HHMI, California Institute of Tech n o l o g y Stanford Uni v e rsity School of Medicine Uni v e rsity of California, Los Angeles
Douglas V. Laurents, PhD – 1997 Sh i vani Nautiyal, PhD – 1999 Roger Sciammas, PhD – 1998 29 Julie Wilson-Annan, PhD – 1999 Instituto de Estructura de la Materia Uni v e rsity of California, San Fra n c i s c o Stanford Uni v e rsity School of Medicine The Walter and Eliza Hall Institute
Bee-Na Lee, PhD – 1997 Erik Nelson, PhD – 200 0 JoAnn M. Sekiguchi, PhD – 1998 30 Catherine A. Wol kow, PhD – 1998 Ha rvard Medical Scho o l Beth Israel Deaconess Medical Center Ch i l d r e n ’s Hospital Bost o n Ma s s a chusetts General Hosp i t a l
Sang Eun Lee, PhD – 1997 Yael Nevo-Caspi, PhD – 1999 Paul Sincock, PhD – 1999 Dong Yu, PhD – 200 0 Brandeis Uni v e rs i t y Tel - Aviv Uni v e rs i t y Stanford Uni v e rsity School of Medicine Princeton Uni v e rs i t y
Bibo Li, PhD – 1998 Ich i ko Nishijima, PhD – 200 0 Cynthia Snyder, MD – 1997 Jinsong Zhang, PhD – 200 0 The Rockefeller Uni v e rs i t y Baylor College of Medicine Uni v e rsity of New Mexico Health Sciences The Rockefeller Uni v e rs i t y
Jianze Li, PhD – 1999 Clodagh O’Shea, PhD – 1999 Robert Sokolic, MD – 200 0 Haiphong Zhong, PhD – 1998 32 Columbia Uni v e rsity Health Sciences Uni v e rsity of California, San Fra n c i s c o Me m o rial Sloan-Ket t e ring Cancer Center HHMI, Yale Uni v e rs i t y
Yong Li, PhD – 1998 Koshi Oishi, MD, PhD – 1999 Su p r i va Srinivasan, PhD – 1999 31 HHMI, California Institute of Tech n o l o g y Fred Hutchinson Cancer Rese a r ch Center Uni v e rsity of California, San Fra n c i s c o
Monika Liljedahl, MD, PhD – 1999 Paula M. Oliver, PhD – 1999 Elaine E. Storm, PhD – 1998 Uni v e rsity of California, San Diego National Jewish Medical & Rese a r ch Center Uni v e rsity of California, San Fra n c i s c o
Young-Mi Lim, PhD – 1998 Kay Keyer Opperman, PhD – 1999 Sh u i chi Tak ayama, PhD – 1998 Uni v e rsity of California, Los Angeles Johns Hopkins Uni v e rsity School of Medicine Ha rvard Uni v e rs i t y
Kuo-I Lin, PhD – 1999 Gabriela C. Per e z - A l varado, PhD – 1997 Wayne Tam, MD, PhD – 200 0 Columbia Uni v e rsity Health Sciences The Scripps Rese a r ch Institute Institute of Cancer Genetics
Me e i -Yun Lin, PhD – 200 0 Toni Portis, PhD – 1999 Idan Tamir, PhD – 1997 Uni v e rsity of California, San Diego Washington Uni v e rsity School of Medicine National Jewish Center
Jinli Liu, MD, PhD – 1999 Kiley Prillman, PhD – 200 0 Matthew Joseph Thomas, PhD – 1999 Yale Uni v e rsity School of Medicine La Jolla Institute for Allergy and Immunology Uni v e rsity of South Flo ri d a
David Loeb, MD, PhD – 200 0 Joe Ramos, PhD – 1997 Randal S. Tibbetts, PhD – 1997 Johns Hopkins Uni v e rsity School of Medicine The Scripps Rese a r ch Institute Duke Uni v e rs i t y
23 Dr. Kim is funded by a generous gift to the 25 Dr. Lutterbach is supported by a generous gift to 27 Dr. Richardson, The Glaxo Wellcome Gertrude B. 32 Dr. Zhong is supported in part by a generous Society from Delora Sanfilippo in memory of Hank the Society from The John and Shirley Davies Elion Fellow of the Leukemia & Lymphoma Society, gift to the Society from the Notarfrancesco Memoria Mo rine and Bob Stauffer. Fou n d a t i o n . is funded by a generous endowment from Glaxo Golf Outing. Wellcome Foundation and Glaxo Wellcome Inc. 24 Dr. Kol esnikova is supported in part by a 26 Dr. Martinez-Hackert is supported by a generous generous gift to the Society from the Family of Anne gift to the Society from the Jane Elissa/Charlotte 28 Dr. Schn a bel is supported in part by a generous Rodin, in her memory. Me y e rs Fun d . gift to the Society from The Valley Fou n d a t i o n .
29 Dr. Sciammas is supported by a generous gift to the Society from the Basso and the Garavano Fam i l i es .
30 Dr. Sekiguchi is supported by a generous gift to the Society from The Richard D. Fris bee III Fou n d a t i o n .
31 Dr. Srinivasan is supported by a generous gift to Research grants—Translational Research Program
Robert Arceci, MD, PhD – 1997 John F. DiPersio, MD, PhD – 1998 Mark L. Heany, MD, PhD – 1998 Giemter Koehne, MD, PhD – 200 0 Ch i l d r e n ’s Hospital Medical Center Washington Uni v e rs i t y Me m o rial Sloan-Ket t e ring Cancer Center Me m o rial Sloan-Ket t e ring Cancer Center
David W. Bahler, MD, PhD – 1998 Kon s tanze Dohner, MD – 200 0 Guillermo Herrara, MD – 1997 Donald B. Kohn, MD – 1997 Uni v e rsity of Pittsburgh Uni v e rsity of Ulm Louisiana State Uni v e rsity Medical Center Ch i l d r e n ’s Hospital Los Angeles
Albert Baldwin, PhD – 1997 Daniel C. Douek, PhD – 1999 35 James Hnatyszyn, PhD – 1998 38 Drishna V. Komanduri, MD – 200 0 Uni v e rsity of North Carolina, Chapel Hill Uni v e rsity of Texas, Dallas Uni v e rsity of Miami Uni v e rsity of Texas, Houston
Ed ward D. Ball, MD – 1996 L. Austin Doyle, MD – 1998 Ronald Hoffman, MD – 1999 St e ven M. Kornblau, MD – 1999 Uni v e rsity of California, San Diego Greenbaum Cancer Center Uni v e rsity of Illinois, Chicag o Uni v e rsity of Texas, Houston
Deborah E. Banker, PhD – 1998 33 Brian J. Druker, MD – 1996 36 Raymond Hohl, MD – 1998 Mark J. Kou r y, MD – 1996 Fred Hutchinson Cancer Rese a r ch Center Oregon Health Sciences Uni v e rs i t y Uni v e rsity of Iowa Vanderbilt Uni v e rs i t y
Peter Leif Bergsagel, MD – 1998 Robert Fenton, MD, PhD – 200 0 Marshall S. Horwitz, MD, PhD – 1999 Diane Krause, MD, PhD – 1998 Weill Medical College of Cornell Uni v e rs i t y Uni v e rsity of Maryl a n d Uni v e rsity of Was h i n g t o n Yale Uni v e rsity School of Medicine
Tim o t hy Bestor, PhD – 1998 34 Harry W. Fin d l e y, PhD – 1999 Robert Hromas, MD – 1998 Lawrence S. Lamb, Jr., PhD – 1999 Columbia Uni v e rsity Health Sciences Em o ry Uni v e rs i t y Indiana Uni v e rs i t y Palmetto Richland Memorial Hosp i t a l
Ravi Bhatia, MD – 1999 Barry A. Finette, MD, PhD – 1997 Frank James Hsu, MD – 1998 Mary J. Laughlin, MD, MS – 1997 40 City of Hope National Medical Center Uni v e rsity of Verm o n t Yale Uni v e rsity School of Medicine Case West e rn Rese rve Uni v e rs i t y
Ivan Borello, MD – 200 0 Rafael Fonseca, MD – 1998 Stephen P. Hunger, MD – 1998 Ming-Sheng Lee, MD – 200 0 Johns Hopkins Uni v e rsity School of Medicine Ma yo Clinic Uni v e rsity of Colorado Health Uni v e rsity of Texas, Houston Sc i e n c es Center H. Scott Boswell, MD – 1998 Joseph Fon tana, MD, PhD – 1998 Jean-Pierre Levesque, PhD – 200 0 Indiana Uni v e rs i t y Wayne State Uni v e rs i t y Mi chael Jensen, MD – 1998 Peter MacCallum Cancer Institute Be ckman Rese a r ch Institute Mi chael Boyer, MD – 1999 Ri chard J. Ford, Jr., MD, PhD – 1998 Bertrand C. Liang, MD – 1998 Em o ry Uni v e rs i t y Uni v e rsity of Texas, Houston Daniel E. Johnson, PhD – 1999 Uni v e rsity of Vermont College of Medicine Uni v e rsity of Pittsburgh William L. Carroll, MD – 1999 Francine Foss, MD – 1996 David N. Liebowitz, MD, PhD – 1997 Huntsman Cancer Institute New England Medical Center Craig T. Jordan, PhD – 1998 Uni v e rsity of Pen n s y l v a n i a Uni v e rsity of Ken t u cky Medical Center Robert P. Castleberry, MD – 1998 Arthur Edward Fra n kel, MD – 1997 Jane Liesveld, MD; Jeffrey Lancet, Uni v e rsity of Alabama, Birmi n g h a m Wake For est Uni v e rs i t y Ri chard P. Junghans, MD, PhD – 1998 MD – 2000 Beth Israel Deaconess Medical Center Uni v e rsity of Roches t e r Kun-Sang Chang, PhD – 1998 Patricia Fraser, MD, MPH- 200 0 Uni v e rsity of Texas, Houston The Center for Blood Rese a r ch Marshall Kadin, MD – 1997 T. Logtenberg, PhD – 200 0 Ha rvard Medical Scho o l Uni v e rsity Medical Center Utr e ch t Curt I. Civin, MD – 200 0 Daniel P. Gold, PhD – 1999 37 Johns Hopkins Uni v e rsity School of Medicine Kimmel Cancer Center Gregory J. Kato, MD – 1999 B. Jack Longley, MD – 1999 Johns Hopkins Uni v e rsity School of Medicine Columbia Uni v e rsity Health Sciences David Claxton, MD – 1997 Jianlin Gong, MD – 200 0 Uni v e rsity of Texas, Houston Da n a - Fa r ber Cancer Institute Emmanuel Katsanis, MD – 1998 David G. Maloney, MD, PhD – 1999 Uni v e rsity of Ariz o n a Fred Hutchinson Cancer Rese a r ch Center John Colicelli, PhD – 1997 Ri chard G. Gorlick, MD – 1999 Uni v e rsity of California, Los Angeles Me m o rial Sloan-Ket t e ring Cancer Center Scott Kaufmann, MD, PhD – 1999 Joan B. Mannick, MD – 1998 Ma yo Clinic Da n a - Fa r ber Cancer Institute Seth J. Corey, MD, MPH – 1997 Els Goulmy, PhD – 1996 Ch i l d r e n ’s Hospital of Pittsburgh Leiden Uni v e rsity Hosp i t a l Brian K. Kay, PhD – 1998 39 Ann Marshak-Rothstein, PhD – 1998 Uni v e rsity of Wisconsin Medical Scho o l Boston Uni v e rsity School of Medicine Bh avana J. Dave, PhD – 1998 St e ven Grant, MD – 1996, 200 0 Uni v e rsity of Nebraska Medical Center Virginia Commonwealth Uni v e rs i t y John T. Kemshead, PhD – 1997 William L. Marshall, MD – 1999 Uni v e rsity of Manches t e r Da n a - Fa r ber Cancer Institute Don J. Diamond, PhD – 1997 Tim o t hy C. Greiner, MD – 200 0 City of Hope National Medical Center Uni v e rsity of Nebraska Medical Center
33 Dr. Banker is funded by a generous gift to the 35 Dr. Douek is supported by a generous gift to the 38 Dr. Hnatyszyn is supported in part by a generous 40 Dr. Laughlin, a Stephen Birnbaum Translational Society from The Chuck Griffin Memorial Society from the St. Val e n t i n e ’s Day Luncheon & gift to the Society by The Gold-Diggers. Research Investigator, is funded by a generous Res e a r ch Program. Style Show. gift to the Society from The Stephen Birnbaum 39 Dr. Kay is supported by a generous gift to Foundation. 34 Dr. Best o r ’s grant is funded by proceeds from the 36 Dr. Druker is supported in part by a generous gift the Society from the Northwestern Mutual We st ch es t e r /Hudson Valley Chapter Annual Ball. to the Society from the G. Edward and Constance M. Foundation, Inc. Mi esel Family Fou n d a t i o n .
37 Dr. Gold is supported by a generous gift to the Society by KEYS. Hector Martinez-Valdez, MD, PhD – 1998 Benjamin E. Rich, PhD – 200 0 Jonathan Uhr, MD – 1997 Uni v e rsity of Texas, Houston Brigham and Wom e n ’s Hosp i t a l Uni v e rsity of Texas, Dallas
W. Stratford May, Jr., MD, PhD – 1998 Alain Rook, MD – 1997 Marcel R.M. van den Brink, MD, Uni v e rsity of Flo rida College of Medicine Uni v e rsity of Pen n s y l v a n i a PhD – 2000 Me m o rial Sloan-Ket t e ring Cancer Center Mark Minden, MD, PhD – 1999 St e ven T. Rosen, MD – 1999 42 On t a rio Cancer Institute No r t h w es t e rn Uni v e rs i t y Frits van Rhee, MD, PhD – 200 0 Palmetto Richland Memorial Hosp i t a l Ramzi Mohammad, PhD – 1996 41 Joseph Rosenblatt, MD – 200 0 Wayne State Uni v e rs i t y Uni v e rsity of Roches t e r Ellen S. Vit e t ta, PhD – 1997, 200 0 Uni v e rsity of Texas, Dallas Jeffrey Molldrem, MD – 1998 Leona Samson, PhD – 1998 Uni v e rsity of Texas, Houston Ha rvard School of Public Health Edmund Waller, MD, PhD – 1997 Em o ry Uni v e rs i t y Ri chard L. Momparler, PhD – 200 0 Daniela Santoli, PhD – 1998 Hˆopital Sainte-Justine The Wistar Institute Paul Weiden, MD – 200 0 Virginia Masor Rese a r ch Center Tuna Mutis, MD, PhD – 1999 Mathias Schmid, MD – 200 0 Leiden Uni v e rsity Medical Center Uni v e rsity of Ulm Bruce Weinberg, MD – 200 0 Duke Uni v e rsity Medical Center Robert S. Negrin, MD – 1998 Jo a chim L. Schultze, MD – 1999 Stanford Uni v e rsity School of Medicine Da n a - Fa r ber Cancer Institute Peter W. Wiernik, MD – 1998 New York Medical College Giuseppina Nuchifora, DSc, PhD - 1999 Paul Schwarzenberger, MD – 1997 Lo yola Uni v e rsity of Chicag o Louisiana State Uni v e rsity Medical Center Qing Yi, MD, PhD – 1999 Uni v e rsity of Arkansas Robert Zygmunt Orlowski, MD, Paul Shami, MD – 1997, 200 0 PhD – 1998 Uni v e rsity of Uta h James W. Young, MD – 1998 Uni v e rsity of North Carolina, Chapel Hill Me m o rial Sloan-Ket t e ring Cancer Center Margaret A. Shipp, MD – 1997, 200 0 Lawrence Panasci, MD – 1998 Da n a - Fa r ber Cancer Institute Alice L. Yu, MD, PhD – 1998 44 Lady Davis Institute for Medical Rese a r ch Uni v e rsity of California, San Diego Donald Small, MD, PhD – 200 0 Linda Z. Penn, PhD – 1998 Johns Hopkins Uni v e rsity School of Medicine John Yu, MD, PhD - 1997 On t a rio Cancer Institute The Scripps Rese a r ch Institute Roger Stair, MD, PhD – 200 0 Sharon E. Plon, MD, PhD – 1998 Uni v e rsity of Medicine & Dentistry Xue-Zhong Yu, MD – 1999 Baylor College of Medicine of New Jerse y Fred Hutchinson Cancer Rese a r ch Center
Joseph Prchal, MD – 1997 Ri chard A. Steinman, MD, PhD – 1998 Lisha Zhang, MD, PhD – 1999 Uni v e rsity of Alabama, Birmi n g h a m Uni v e rsity of Pittsburgh School of Medicine Uni v e rsity of Texas, Houston
Shahin Rafii, MD – 200 0 Jeffrey W. Taub, MD – 1997 Weill Medical College of Cornell Uni v e rs i t y Wayne State Uni v e rs i t y
S. Vincent Rajkumar, MD – 1999 Daniel G. Tenen, MD – 200 0 Ma yo Clinic Beth Israel Deaconess Medical Center
Mariusz Z. Rarajczak, MD, PhD – 1999 Nelson Teng, MD, PhD – 1997 Uni v e rsity of Pen n s y l v a n i a Stanford Uni v e rsity School of Medicine
Robert L. Redner, MD – 1999 Helen Tighe, PhD – 1999 43 Uni v e rsity of Pittsburgh Uni v e rsity of California, San Diego
Yair Reisner, PhD – 1998 Fatih M. Uckun, MD, PhD – 1998 Weizmann Institute of Science Wayne Hughes Institute
41 Dr. Mohammad is supported in part by a 42 Dr. Rosen is supported by a generous gift to the 44 Dr. Yu is supported by a generous gift to the generous gift to the Society from the Jim Jacobs Society from the Dr. Ralph & Marion Falk Medical Society by KEYS. Leukemia Rese a r ch Fun d . Res e a r ch Tru s t .
43 Dr. Tighe is funded by a generous gift to the Society from The Chuck Griffin Memorial Rese a r ch Pr o g r a m . Donors
Research PricewaterhouseCoopers LLP Canyon Springs Development Pro-Cuts Capital Group Companies $1,000,000 and above The Family of Ann Rodin Carrs-Gottstein Foods/Safeway United Food & Commercial Workers Sigma Alpha Epsilon Fraternity, Cell Therapeutics, Inc. International Union University of Georgia Central Texas Association of Bass Clubs Robert Stiffel Trust Dorothy M. Culbertson $100,000-$499,999 Speer, Leeds & Kellogg Frances M. Day The Stephen Birnbaum Foundation Mr. and Mrs. Gillis Thomas O. Paul Decker Memorial Foundation John and Shirley Davies Foundation West Family The Draper Foundation Ralph & Marian Falk Medical Xcelerate Corp. Employees Community Fund of Research Trust Boeing St. Louis Glaxo Wellcome Foundation Patient Services Marcel & Francine Gani Glaxo Wellcome Inc. William and Nadine Gibson Family The Karyn Glick Special Fellowship $100,000-$499,999 Foundation Leslie Elliot Krause, Esq. Ortho Biotech Mark Grace Foundation Quality Food Centers/Chuck Griffin Heinz USA Memorial Research Program $50,000-$99,999 The Hellis Foundation Carl Rosen Translational Research Fund Amgen Hewitt Family Foundation Genentech Highmark BlueCross BlueShield $50,000-$99,999 Novartis Margaret Ingold Charities 2000 The Dan Jansen Foundation, Inc. Diamond Ball/Ed Heitz Memorial $10,000-$49,999 Kate M. Kelley Foundation Research Fund The Stanley E. Brown Foundation Kenetch Energy Systems, Inc. Hildegarde D. Becher Foundation, Inc. Canyon Springs Development Jack J. Kessler, Esq. Jane Elyssa/Charlotte Meyers Fund The Entertainment Industry Foundation Mr. Sanjay Kumar Pete Harman IDEC Mario Lemieux Foundation Jim Jacobs Leukemia Research Fund Milwaukee Foundation Michael & Nicole Lincoln Philip Ozersky New York State Department of Health at the Jeffrey & Ingrid Lion The Reichman Memorial & request of Senator Charles J. Fuschillo, Jr. The Marcus Family The Altschul Foundation Pall Corp. Douglas Marshall Delora Sanfilippo Restaurant Concepts Mark E. Mason Dr. Scholl Foundation SuperGen Bruce Matthews Harold Simmons Memorial Golf Wyeth/Genetic Institute Mary Kay McCaw The Valley Foundation The McCutchen Foundation Bone Marrow Drives Mike McKernan $10,000-$49,999 Microsoft Alabama Power Company $10,000-$49,999 Michael Nash American Airlines The Everhealth Foundation Sheryl & Peter Neupert In Memory of Dr. Jerry Anderson F.M. Kirby Foundation The New York Community Trust Hamilton Ansley Research Fund Milwaukee Foundation Tom and Cathy O’Keefe The Beazley Foundation The Perfect Match Golf Classic Mr. & Mrs. Richard G. Post The Berner Charitable and Rotary International District 5130 Michael Rona Scholarship Foundation Rotary International District 5170 Sarver Charitable Foundation Baker Botts Edith M. Schweckendieck Trusts Helen V. Brach Foundation Total Program Scott Foundation The Breeden-Adams Foundation The Sidney, Milton & Leoma Simon Cadillac Plastics $100,000-$499,999 Foundation The Gail Cohen Leukemia Fund 10th Annual San Antonio Golf Classic Phil and Sally Smart The Coleman Foundation Chase Manhattan Bank Phil Smart, Inc. Mr. Raymond M. Dunning, Jr. Citibank, NA Carmine Smeraldo Mr. and Mrs. Craig Evans Rush Limbaugh Speedway Children’s Charities Mr. and Mrs. Fred Fischer Garrett Stauffer, CPA The Richard D. Frisbee I II Foundation $50,000-$99,999 Todd Stottlemyre Grant Healthcare Foundation Cindy Crawford Michael Sweig Key Food Stores Foundation, Inc. Vesta Durbin Robert & Jane Tschudy KEYS The Robert R. McCormick Tribune University Sports Publications F.M. Kirby Foundation Foundation Roseann Waindel Foundation Carmella Kramer Memorial Foundation, Inc. Wallmart Jim and Dixie Kreider Charles B. Wang Foundation Board and Staff, The Leukemia & $10,000-$49,999 WAWA Incorporated Lymphoma Society, Northern Andrew Arthur Harry & Jeanette Weinberg Foundation, Inc. California Chapter Auburn University/Panhellinic Wells Fargo Bank Lewisville Memorial Hospital The Sandra Atlas Bass and Edythe & Sol G. Mr. & Mrs. John C. Whetstone Local 148 Operating Engineers Atlas Fund Pamela Whorton McCullough Foundation Alan Benaroya Stuart A. Williams, Esq. Bob McKown Memorial Assoc. Larry and Sherri Benaroya Rod Woodson Mercedes Benz Credit Corp. Mr. and Mrs. Joe Besecker Nokia Catherine Boshaw Notarfrancesco Memorial Golf Outing James E. Bridges Northwestern Mutual Life Foundation The Florence and Arthur Brock Parents Against Leukemia Family Foundation Ed & H Pillsbury Foundation Scott Bruin Prefererd Health Systems Mr. & Mrs. Joseph Bruno Organizational Partnerships
Sp o n s o r s h i p s John and Shirley Davies Mellon Bank Walt Disney Memorial Cancer Institute at Susan Davis Interna t i o n a l Meltzer Schiner & Caroll, LLC Flo rida Hosp i t a l $50 0 , 0 0 0 - $ 999 , 999 Deloitte & Tou ch e Me m o rial Health Washington Gas Chase Manhattan Bank Delta Airlines Me r cantile-Safe Deposit & Trust Company Waste Management De u t s che Bank Me r chants Bank Watson Wyatt Wor l d w i d e $1 0 0 , 0 0 0 - $ 499 , 999 The Document Company - Xer ox Me r ck & Co., Inc. WB33 Charit i es Fund of Robert R. Am e ri can Bicycle Association Dodge Different Me r rill Lyn ch Mc C o rm i ck Tribune Fou n d a t i o n Donaldson, Lufkin & Jenrette Me t a bo l i f e Weil, Gotschal & Manges LLP $50 , 0 0 0 - $ 99 , 999 Hardy & Hayes, John D. Betres The Mills Corporation Weitz & Luxenber g An chor Bancorp, Inc. ELG Haniel Metals Corp. Montpellier Reso u r c es Wells Fargo Bank Bank of America Emily Water Company Morgan Kee g a n Whi t t m a n - H a r t Ch ry s l e r /P l y m o u t h EON, Inc. Morgan Stanley Dean Wit t e r WRQ, Inc. Cu m berland Packing Corp./Sweet ’N Low Ernst & Young LLP Mike Muncha k Yellow Corporation Ge n e n t e ch, Inc./IDEC Pharma c e u t i ca l s Fannie Mae Fou n d a t i o n National City Bank, Pen n s y l v a n i a Co r p o r a t i o n Fifth Third Bank National Rural Uti l i t i es Cooperative Fin a n c e Pr o m o ti o n s Me r c e d es - B e n z Fight for Children Co r p o r a t i o n Novartis Oncology Food Service Management, Dominic Abbot t The Niello Company $1,000,000 and above Sallie Mae Foodland Independent Retailers No Name Steaks The Olive Garden Italian Rest a u r a n t Sa u c o ny TM The Ford Motor Company North American Operations Di a l A m e ri ca Marketing United Airlines Freddie Mac Or a c l e The Wallis Fou n d a t i o n FutureNext Consulting, Inc. Ortho Biotech $50 0 , 0 0 0 - $ 999 , 0 0 0 The Videre Group, LLP The Gap Pat Gallagher, PGT Tru cking Inc. KGO Newstalk AM810 GE Lighting PepsiCo Fou n d a t i o n $1 0 , 0 0 0 - $ 49 , 999 Getz Fou n d a t i o n Pep s i - C o l a $1 0 0 , 0 0 0 - $ 499 , 999 Acordia South Flo ri d a Gibson Musical Instruments Pf i z e r, Inc. Rhubarb Jones Ado be Systems, Inc. Goldman Sachs & Co. Ph a rmacia Corporation SC A NA Alaska Airlines Grubb & Ellis Phi Gamma Delta Fra t e rn i t y Sunflower Opera Company Alliance Steel Gwinnett Place Honda Planned Systems International, Inc. WYAY-FM Y106.7 Hit Country Am e ri can Airlines Halliburton Energy Servi c es Pl u m be rs & Pipefitters Local Union 72 WBZ Charit i es Am e ri can Invest o rs Ha r ris Bank PNC Bank, Pittsburgh, PA Am e ri t e ch Ha r ris Beach Wil c ox, LLP Price Modern, Inc. $1 0 , 0 0 0 - $ 49 , 999 An d e rsen Consulting Ha r ris Marketing Group Pri c e w a t e r h o u s e C o o p e rs LLP Adelphia Cable Peter & Georgia Angelos Fou n d a t i o n He rshey Park Arena and Hocke y Provident Bank Azo, Inc. An h e u s e r - B u s ch The Hilton Was h i n g t o n Putnam Allstate Adv i s o r Ca l i f o rnia-Nevada Operating Engineers Arnold & Por t e r Hoenig & Co., Inc. Reliant Energy Coastal Corporation Ascension Parish Leukemia/Cancer Freddie Hoffman Russell Reynolds Associates Cohutta Wat e r Fun d r a i s e r Hoffman-La Roche S&C Electric Co i n s t a r AT &T Fou n d a t i o n IBM Sa f e c o Ho o t e rs B & B Washington's Caterer Ic o n i x Salomon Smith Barne y Houston Mercedes Benz Bag & Save Superma r k e t s IMC, Inc. San Diego Chargers Infinity Broadcasting Corp. Bank One Infinity Outdoor Sch e ring Labor a t o ri es Ja z z e r c i s e BBDO Detroit, Inc. In t e rnational House of Pan ca k es Se rvicemark Communicat i o n s JNS Consulting Engineers, Inc. BellSouth Mobility JFK Medical Center Sh e a rman & Sterling The Kroger Co. Berlex Labor a t o ri es Johnson & Johnson The Sheakley Group of Companies KZSN Radio Bert Smith & Co. Johnson & Johnson Search America Silicon Graphics Ladd-Hanford Chrys l e r - P l y m o u t h - D o d g e - BET Holdings, Inc. J. P. Morgan & Co. Smart DM Je e p - M a z d a Bitco Enterpris es John Kel l e n y i Sm i t h - C a i rn s Mighty Tac o Bl u e C r oss BlueShield of Californi a Kemira Pigments, Inc. Snyder Communications, Inc. Miller Brewing Company Bl u e C r oss BlueShield of Mississippi Key Bank So n n y ’s Real-Pit Bar-B-Q Music City 103 Bl u e C r oss BlueShield of New Jerse y Key Clubs of Central Pen n s y l v a n i a Sony Digital Audio Disc Corporation Nashville Scene Bowne Business Solutions Key Food Stores Foundation, Inc. So u t h e rn Cultural Heritage Corporation No r t h w est Airlines AirCares Program BP Amoco Kirkland & Ellis Sp e e r, Leeds & Kel l o g g O’ C h a r l e y ’s, Inc. Bristol Mye rs Squibb Children of Maryanne & Henry J. Knott, Jr. Sp rint PCS Ou t b a ck Steakhouse British Aer os p a c e Kojaian Management Corporation Star Acq u i s i t i o n s Pennsylvania District Key Clubs British Airwa y s KPMG LLP Steele Enterpris es Pennsylvania Physicians Care Brown & Wood LLP Lafarge Corp. STX, Inc. Realm Charity Golf Butera Properties Lake Stockton Yacht Club Sullivan Papain Block McGrath Cannavo The Regence Group Ca m p bell & Company La k eside Building Maintenance Su p e r Value, Pittsburgh, PA Bl u e C r oss BlueShield of Oregon Capital One Lamarque Motor Corporation Sutler Cancer Center Bl u e C r oss BlueShield of Uta h Ci n e r g y LaSalle Bank Tafel Motor Company Bl u e C r oss BlueShield of Was h i n g t o n Cl a r k /B a r d es, Inc. Theodore Lazzaro, D.M.D., M.D., LTD. Tel i g e n t Regence Life & Health Classic Auto Coupons Leiner Health Products/Your Life Vit a m i n s Tenet Louisiana Healthsystem Joseph Rosi Jewelers Cl e a ry, Gottlieb, Steen & Hamilton Levi Strauss & Co. Ro bert E. Torray & Co. Inc. Safeway Stores, Inc. Cleveland Clinic Li berty Media Holdings Tra v e l e rs Express Sa t u rn of Harris b u r g Clipper Navigation Litton PRC Tul l y ’s Coffee Shults For d Co m ca s t Lo ckheed Martin Global Tel e c o m m u n i ca t i o n s Turner Construction So u t h Pa r k Comercia Bank Logicon Incorporated, a Northrop Grumman Uk r o p ’s Thomas Sumter ACA Derry Computer Science Corporation Co m p a n y Uni v e rsity of Pittsburgh Medical Center Timal Automotive Servi c es Philip S. Contacos Lu n a r d i ’s Superma r k e t s UPMC Health Systems Villa Pizza Corporate Express Business Interio rs Margaret McCarthy Fou n d a t i o n US Airwa y s Volvo Cars of North America Costco Who l es a l e Ma r riott Interna t i o n a l UUNET WFBQ Radio – The Bob & Tom Show Coulter Pharma c e u t i ca l s Ma rsh USA, Inc. Valley Lexus WIVB-TV Ro bert Coury Massey Charitable Tru s t Verizon Communicat i o n s WJYE - FM Credit Suisse/First Boston Corporation MBNA Virginia Oncology Association WZTV Fox 17 Di l Ch l AG RldMDldHChiti Vl C fN thA i Report of independent auditors
Board of Tru s t e e s
The Leukemia & Lymphoma Society, Inc.:
We have audited the accompanying consolidated statement of financial position of The Leukemia & Lymphoma Society, Inc. (the Society) as of June 30, 2000, and the related statements of activities, cash flows and functional expenses for the year then ended. These consolidated financial statements are the responsibility of the Society’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audit. The prior year summariz e d comparative information has been derived from the Society’s 1999 consolidated financial statements and, in our report dated September 30, 1999, we expressed an unqualified opinion on those statements.
We conducted our audit in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present fa i r l y, in all material respects, the financial position of The Leukemia & Lym p h o m a So c i e t y, Inc. as of June 30, 2000, and the cha n g es in its net assets and its cash flows for the year then ended in conformity with accounting prin c i p l es generally accepted in the United States of America .
Oc t o ber 10, 200 0 New York, New Yor k Consolidated Statement of Financial Position The Leukemia & Lymphoma Society, Inc. une 30, 2000 (with comparative amounts at June 30, 1999) (in thousands)
20 0 019 9 9
As s e ts
Cash and cash equivalents ...... $ 11,114 $ 22 ,3 8 5 Accounts receivable ...... 1,0 3 41,15 8 Le gacies and contributions receivable (note 2) ...... 2, 59 82 ,115 Prepaid expenses ...... 2, 42 08 6 0 Investments, at fair value (note 3) ...... 67,3544 0 , 5 4 4 Equipment and leasehold improvements, less accumulated depreciation and amortization of $1,6 8 5and $1,107 ...... 2, 478 1,80 5
Total assets ...... $ 86 , 9 9 8$6 8 ,8 67
Li a b i l i ties and Net Assets
Li a b i l i t i e s : Accounts payable and accrued expenses ...... $ 7,6 42 $ 6,79 6 Deferred revenue ...... 3, 413 2,7 74 Grants payable (note 4) ...... 34 , 25 626 , 015 Total liabilities ...... 45 ,311 35, 5 8 5
Net assets: Un r e s t r i c t e d ...... 39, 255 30 ,701 Tem p o rarily restricted (note 7) ...... 1,371 1,6 0 8 Permanently restricted (note 7) ...... 1,0 61 973 Total net assets ...... 41,6 87 33, 28 2
Total liabilities and net assets ...... $ 86 , 9 9 8$6 8 ,8 67
See accompanying notes to consolidated financial statements. Consolidated Statement of Activities he Leukemia & Lymphoma Society, Inc. Yea r ended June 30, 2000 (with comparative totals for the year ended June 30, 1999) in thousands)
Tem p o ra r i l yPe r m a n e n t l yTo t a l Un r e s t r i c t e dR e s t r i c t e dR e s t r i c t e d2 0 0 019 9 9
Op e ra ting Rev e n u e
Campaign contributions ...... $ 151,85 8$ 30 5$ 88$152 , 251 $ 125, 5 6 0 Less direct donor benefit costs ...... (28, 25 8 )--(28 , 25 8 )(24 ,8 9 5 ) Net campaign contributions ...... 123 , 6 0 03 0 58 812 3 , 9 93 100 , 6 6 5 Le ga c i e s ...... 5,8 6 6--5 ,8 6 63 ,3 41 Net interest and dividend income (no t e3) ...... 2, 0 07 19 - 2, 0 26 1,59 4 Net appreciation in fair value of investments ...... 653 103-75 61, 0 4 6 Grant refunds ...... 794--79 452 9 Net assets released from restrictions ...... 66 4( 6 6 4 )- - - Total operating revenue ...... 133, 5 8 4(2 37 )8 8133 , 435 107,175
Op e ra ting Expenses (no te 8)
Pro g ram Se rvi c e s : Re s e a r c h ...... 33,197 - - 33,197 24,359 Patient and community servi c e ...... 35, 2 0 0--35 , 2 0 0 27,132 Public health education ...... 20 , 9 87 - - 20 , 9 87 16, 939 Professional education ...... 5,72 2--5 ,72 24 , 6 93 Total program servi c e s ...... 95 ,10 6--9 5 ,10 673 ,12 3
Su p p o rting Se rvi c e s : Ma n a gement and gen e ra l ...... 8, 9 8 3--8 , 9 8 37,7 71 Fund rai s i n g ...... 20 , 9 41 - - 20 , 9 41 15, 626 Total supporting servi c e s ...... 29 , 924 - - 29 , 924 23 ,397
Total operating expenses ...... 125, 0 3 0--125 , 0 3 09 6 , 52 0
Ch a n ge in net assets ...... 8, 55 4(2 37 )8 88 , 4 0 510 , 6 55
Net Assets
Beginning of year ...... 30 ,701 1,6 0 897333 , 28 22 2 , 627 End of year ...... $ 39, 255 $ 1,371 $ 1,0 61 $ 41,6 87 $ 33, 28 2 Consolidated Statement of Cash Flows The Leukemia & Lymphoma Society, Inc. Yea r ended June 30, 2000 (with comparative amounts for the year ended June 30, 1999) in thousands)
20 0 019 9 9
Cash flows from operating activ i ti e s :
Ch a n ge in net assets ...... $ 8, 4 0 5$10 , 6 55
Adjustments to reconcile change in net assets to net cash provided by operating activities:
Net appreciation in fair value of investments ...... (756 )(1, 0 47 ) Permanently restricted campaign contributions ...... (8 8 )( 5 8 0 ) Depreciation and amorti z a t i o n ...... 578 667
Ch a n ges in assets and liabilities:
Decrease (increase) in accounts receivable ...... 124 (6 67 ) Increase in legacies and contributions receivable ...... (48 3) (8 0 0 ) Increase in prepaid expenses ...... (1,5 6 0 )(3 0 3) Increase in accounts payable and accrued expenses ...... 84 61, 524 Increase in deferred revenue ...... 639 776 Increase in grants payable ...... 8, 241 4,19 6 Net cash provided by operating activ i ti e s ...... 15, 9 4 614 , 421
Cash flows from investing activ i ti e s :
Purchases of equipment and leasehold improvements ...... (1,251) (93 8 ) Purchases of investments, net ...... (26, 0 5 4 )( 6 ,3 8 8 ) Net cash used in investing activ i ti e s ...... (27,30 5 )(7,326 )
Cash flows from financing activ i ti e s :
Permanently restricted campaign contributions ...... 885 8 0 Net cash provided by financing activ i ti e s ...... 885 8 0
Net (decrease) increase in cash and cash equivalents ...... (11,271) 7,675 Cash and cash equivalents at beginning of year ...... 22 ,3 8 514 ,710 Cash and cash equivalents at end of year ...... $ 11,114 $ 22 ,3 8 5
See accompanying notes to consolidated financial statements. Consolidated Statement of Functional Expenses The Leukemia & Lymphoma Society, Inc. Yea r ended June 30, 2000 (with comparative totals for the year ended June 30, 1999) (in thousands)
Pr o g ram Servi c e sS u p p o rting Servi c e s Pat i e n t an dP u b l i cM a n a ge- Tot a l Direct donor co m m u n i ty he a l t hP r o f e s s i o n a lment andFu n d benefit costs Re s e a r c hs e rv i c ee d u c a t i o ne d u c a t i o nTo t a lge n e ra lra i s i n gTo t a l2 0 0 019 9 92 0 0 019 9 9
Aw a rds and gran t s . . . . $31,8 4 9$ -$ -$ -$31,8 4 9$ -$ -$ -$31,8 4 9$ 2 3 , 4 9 5$ -$ - Financial aid to patients . - 3,8 0 8--3 ,8 0 8---3 ,8 0 82 ,751 - - Sa l a r i e s ...... 24912 ,752 6, 251 2, 251 21,5 0 33 , 0 26 4, 425 7,4 51 28, 9 5 42 2 , 24 9-- Employee benefits and taxes (note 5) . . . 442 ,32 91,3514 57 4,181 631 1,0 2 01, 6 51 5,8 32 4, 0 61 - - Oc c u p a n cy (note 6) . . . 12 1,4 4 48 8 23162 , 6 5 44 07 60 91, 016 3, 670 3,79 6-- In s u ra n c e ...... 4 105732 02 0 2336710 03 0 228 6-- Tel e p h o n e ...... 8 697 662 1381, 5 0 519 09131,10 32 , 6 0 82 , 319 - - Trav e l ...... 2978 94 5 4 162 1,43 42183 4 55 6 31, 9 97 1,6 8 316 , 6 87 16, 473 Printing and supplies . . 252 4,731 4,19 58 32 10, 010 2,127 4, 9 9 8 7,125 17,135 14, 262 4, 539 4, 014 Equipment rentals . . . . 13 7855 01 1661, 4 6 52 3 03 8 66162 , 0 81 1,2 0 4-- Pos t a ge and shipping . . 362 ,137 2, 2 2 23924 ,787 54 03 , 0 59 3, 59 98 ,3 8 66 ,8 35 - - Me e t i n g s ...... 142 1,4 5 86 97 253 2, 55 031653 48 5 03 , 4 0 02 ,8 51 1,89 06 5 4 Professional fees ...... 5303 , 274 3,14 85 41 7,4 93 1,011 4,18 95 , 2 0 012 , 6 93 9, 2 27 2, 576 2,79 5 Mi s c e l l a n e o u s ...... 236 8 34121521, 270 19027 74 67 1,737 83 42 , 5 6 69 59 Depreciation and am o rt i z a t i o n ...... 6 20 8 139 42 3956 411918 3 578 667 - - Total expenses ...... $33 ,197 $35 , 2 0 0$ 2 0 , 9 87 $5 ,72 2$ 9 5 ,10 6$ 8 , 9 8 3$ 2 0 , 9 41 $2 9 , 924 $125, 0 3 0$ 9 6 , 52 0$ 28 , 25 8$ 24 ,8 9 5
Fiscal year 2000 functional expenses
Research 26.5%
Patient and Community Service 28.2%
Supporting Services Public Health Education 16.8% 23.9%
Professional Education 4.6%
Program Services M a n a gement and General 7.2% 76.1%
Fund Raising 16.7%
See accompanying notes to consolidated financial statements. Notes to Consolidated Financial Statements he Leukemia & Lymphoma Society, Inc. une 30, 2000 (with comparative amounts as of and for the year ended June 30, 1999)
1. Organization and Significant Accounting Policies res t rictions. Tem p o r a rily rest ricted contributions that are received and expended in the same period are reported as unrest ricted contributions. Conditional contrib u- Organization tions are recognized as revenue when the conditions have been substantially met. The Leukemia & Lymphoma Society, Inc. (formerly Leukemia Society of America , Deferred revenue includes amounts received for special events that will be held Inc.) (the “Society”) is a national not-for-profit health agency dedicated to seeking subsequent to the fiscal year-end. the cause and eventual cure of leukemia, lymphoma, Hodgkin’s disease and myeloma and improving the quality of life of patients and their families. The Soci- Donated Services et y ’s principal activities, which are conducted through its local cha p t e rs and the A substantial number of volunteers have made significant contributions of their Home Office, include: awarding rese a r ch grants; facilitating psychosocial support time to help develop the Society’s programs and activities. The value of such volun- groups; providing financial aid to patients; answering phone requests for blood- teer servi c es has not been reflected in the accompanying consolidated financial related cancer information made to the Society’s Information Resource Center; and statements as it does not meet the crit e ria for revenue recognition. disseminating educational information about blood-related can c e rs in the form of pu b l i cations, internet sites and symposia sponsorship for both the medical commu- Cash Equivalents nity and the general public. Cash equivalents consist of money market accounts and short-term invest m e n t s with a maturity of three months or less from date of purcha s e . Tax-Exempt Status The Society qualifies as a cha ritable organization as defined by Internal Revenue Equipment, Leasehold Improvements and Depreciation Code Section 501(c)(3) and, accordingly, is exempt from federal income taxes under Equipment and leasehold improvements are recorded at cost, if purchased, or at In t e rnal Revenue Code Section 501(a). Add i t i o n a l l y, since the Society is publicly- fair value at date of donation, if contributed, and are depreciated or amortized supported, contributions to the Society qualify for the maximum cha ritable contri- using the straight-line method over the estimated useful lives of the assets or the bution deduction under the Internal Revenue Code. te rms of the leases, if shorter.
Principles of Consolidation Estimates The accompanying consolidated financial statements include the accounts of the The preparation of financial statements in conformity with generally accepted So c i e t y, which encompasses the Home Office of the Society and its fifty-seven accounting prin c i p l es requires the Society’s management to make est i m a t es and cha p t e rs, as well as its not-for-profit affiliates, Leukemia Society Rese a r ch Pro- assumptions that affect the amounts reported in the financial statements and grams, Inc. and Leukemia Society of America Rese a r ch Foundation. All significan t accompanying notes. Actual results could differ from those est i m a t es . intercompany and intra-Society accounts and transactions have been eliminated in co n s o l i d a t i o n . Summarized Financial Information The financial statements are presented with 1999 comparative information. Wit h Net Asset Classifications respect to the statement of activities, such prior year information is not prese n t e d To ensure observance of limitations and rest rictions placed on the use of reso u r c es by net assets class and, in the statement of functional expenses, 1999 expenses by available to the Society, funds that have similar cha r a c t e ristics have been classified object are presented in total rather than by functional cat e g o ry. Acc o r d i n g l y, such into three net asset cat e g o ri es as follows: in f o rmation should be read in conjunction with the Society’s 1999 financial state- ments from which the summarized information was derived. Unrestricted net assets: Consist of funds that are fully available, at the discretion of the Board of Tru s t e es, for the Society to utilize in any of its programs or supporting 2. Legacies and Contributions Receivable se rv i c es . The Society’s legacies and contributions receivable at June 30, 2000 and 1999 Temporarily restricted net assets: Consist of funds that are rest ricted by donors for consist of unconditional promises to give, prim a rily in the form of legacies for a specific time period or purpose, as well as amounts relating to term endowment wh i ch the underlying wills have been declared valid by the probate court and no or deferred giving arrangements in which the funds must be maintained intact other conditions are required to be met. Amounts are scheduled to be received as over the lifetimes of the donors. follows (in thousands):
Permanently restricted net assets: Consist of funds that contain donor-impose d res t rictions requiring that the principal be invested in perpetuity and that only the income be used. Income earned on these funds may be unrest ricted or temporaril y 20 0 019 9 9 res t ricted, depending upon the donor-imposed rest ri c t i o n s . Less than one year ...... $ 2,351 $ 1,86 8
Contributions and Deferred Reve n u e Aft e r 5 years ...... 353 353 Co n t ributions are recorded as revenue, at their fair value, when received or 2,70 42 , 2 21 promised unconditionally. Contributions received with donor rest rictions that limit Less discount to present value their use are reported as either temporarily or permanently rest ricted revenue. (discount rate – 6.5%) ...... (106) (106 ) When a donor rest riction is met through the passage of time or fulfillment of a Tot a l ...... $ 2, 59 8$2 ,115 pu r p ose rest riction, temporarily rest ricted net assets are reclassified to unrest ri c t e d net assets and reported in the statement of activities as net assets released from 3. Investments In July 2000, the Society moved its Home Office from midtown Manhattan to Whi t e Plains, New York, and entered into a ten year lease. Fis cal 1999 occupancy expense The following is a summary of investments at June 30, 2000 and 1999 (in thou- in c l u d es $700,000 related to the early termination of the New York City lease. sands): The approximate minimum future annual rental commitments, are summarized as 20 0 019 9 9 follows (in thousands): Cost or Cost or Donated Fai r Donated Fai r Val u eVa l u eVa l u eVa l u e Yea r ended June 30: Money market funds . . . . . $ 35,325 $35,325 $ 14, 552 $ 14, 552 20 01 ...... $ 2,792 Co r p o rate notes 20 0 2 ...... 2,8 92 and bonds ...... 14, 0 9 914 , 2 0 915 ,10 815 , 074 20 0 3 ...... 2, 6 9 8 Common stocks and mutual funds ...... 15,311 17,2 0 07,8 55 9, 259 2004 ...... 2, 261
U. S. Government 20 0 5 ...... 3,73 0 ob l i ga t i o n s ...... 5585 62 1,6 0 91, 6 01 Th e r e a ft e r ...... 6,125 Ot h e r ...... 585 85 85 8 Tot a l ...... $20,498 Tot a l ...... $ 65,351 $ 67,354$39 ,18 2$4 0 , 5 4 4 7. Temporarily and Permanently Restricted Net Assets
Debt and equity securit i es are recorded at fair value as determined by quoted Tem p o r a rily rest ricted net assets and the income earned on permanently rest ri c t e d market pric es. Mutual funds are recorded at fair value using published unit values. net assets were available for the following purposes at June 30, 2000 and 1999 (in In v estment expenses of $172,000 and $132,000 have been netted against interest th o u s a n d s ) : and dividend income for the years ended June 30, 2000 and 1999, resp e c t i v e l y. 20 0 019 9 9 Tem p o rarily Per m a n e n t l yTe m p o rarily Per m a n e n t l y 4. Awards and Grants Restricted Restricted Restricted Re s t r i c t e d Research program ...... $ 60 5$1, 017 $ 628 $ 930 Awards and grants for rese a r ch are recognized as expense in the year approved by Patient service and the Society’s Board of Tru s t e es. Multi-year grants, which are generally two to five bone marrow donor ye a rs in length, are approved on an annual basis and may be terminated at the pr o g ra m s ...... 374 - 653 - discretion of the Society’s Board of Tru s t e es. In addition to unconditional grants pa yable of $34, 2 56,000 at June 30, 2000, the Society has grant commitments of Professional education $5 2 , 344,000 that are conditioned upon future events. pr o g ram ...... 504 44 043 O t h e rp r o g ra m s ...... 342 - 287 - The Society has announced the creation of a major new rese a r ch program entitled Tot a l ...... $ 1,371 $ 1,0 61 $ 1,6 0 8$ 973 Specialized Centers of Rese a r ch (“SCOR”). In fiscal 2000, three of these five-year grants, each providing support of up to $1,500,000 per year and subject to annual re v i e w, were awarded to cross - d i s c i p l i n a ry rese a r ch teams based on a competitive 8. Joint Costs Allocation review of applications by the Society’s Medical and Scientific Committee. In 2000 and 1999, the Society incurred joint costs for informational materials and 5. Pension Plan ac t i v i t i es that included fund raising appeals as follows (in thousands):
The Society has a noncontrib u t o ry, defined contribution 403(b) pension plan 20 0 019 9 9 co v e ring all employees meeting age and service requirements. Contributions are Fund rai s i n g ...... $ 9,332 $ 6, 2 0 3 based on a percentage of each eligible employee’s salary and years of service. Patient and community servi c e ...... 1,315 1,0 9 0 In fiscal 2000, following a study of pension benefits provided by peer and other organizations, the Society enhanced its plan. Expense under this plan aggregated Public health education ...... 4, 539 3, 591 $1 , 1 81,000 and $694,000 for the years ended June 30, 2000 and 1999, resp e c t i v e l y. Tot a l ...... $ 15,18 6$10 ,8 8 4
6. Occupancy Expense and Lease Commitments In fiscal 2000, the Society adopted the provisions of AICPA Statement of Posi t i o n The leases for premises which the Society’s Home Office and cha p t e rs occupy expire (S OP) 98-2, “Accounting for Costs of Act i v i t i es of Not-for-Profit Organizations and on various dates through June 30, 2010 and provide for certain payments subject to State and Local Government Entities That Include Fund Raising.” Since the Society escalation and periodic rate increases relating to real estate taxes, operating expens- continued to meet the crit e ria for allocation, the new SOP had no significant effect. es and utilities. National leaders
Chairman of the Board Paul Calabresi, MD Paul N. Fri m m e r Dan J. Jordanger Ch a i rman Emeritus, Department Irell & Manella LLP Par t n e r Jay L. Silver of Medicine Los Angeles, CA Hunton & Wil l i a m s Sugar Land, TX Brown Uni v e rsity School of Medicine Ri chmond, VA Rhode Island Hosp i t a l Christine K. Fri s b e e Vice Chairman Providence, RI New Canaan, CT John M. Kam i n s Par t n e r Peter J. Quesenberry, MD Kathryn L. Calame, PhD Ri chard Garrison Honigman Miller Schwartz and Cohn Pr o f essor of Medicine Department of Microbiology Pr esident and Owner Detroit, MI Boston Uni v e rsity (appointment pending) College of Physicians and Surgeons Advertising Novelty Co., Inc. Director of Rese a r ch Columbia Uni v e rs i t y Washington, DC Judith E. Karp, MD Roger Williams Hosp i t a l New York, NY Pr o f essor of Medicine Providence, RI John A. Geoghegan Greenebaum Cancer Center Robert A. "Spider" Cantley Gellert and Cutler, PC Uni v e rsity of Maryland Medical Sys t e m s Vice Chairman for Medical and The Insulation Co. Pu r chase, NY Baltimore, MA Sc i e n tific Affairs Fremont, CA Alan M. Gewirtz, MD Virginia Lee Kintz W. Stratford May, Jr., MD, PhD John M. Coffin, PhD Stem Cell Biology and Therapeutic Program Master Long Term Care Represe n t a t i v e Di r e c t o r Pr o f essor of Microbiology Uni v e rsity of Pennsylvania School GE Financial Assurance Shands Cancer Center, Uni v e rsity of Flo rida Tufts Uni v e rsity School of Medicine of Medicine Sch o h a rie, NY Ga i n esville, FL Boston, MA Philadelphia, PA Leslie Elliot Krause, Esq. Se c r e ta ry / Tr e a s u r e r Mi chael Copley Paul G. Glaab Krause & Kra u s e Vice Chairman, Board of Tru s t e es Laguna Niguel, CA New York, NY Ri chard A. Fes s Ch i l d r e n ’s Hospital Fou n d a t i o n Pr es i d e n t San Diego, CA Keith P. Harenda William S. Lear Mi d - Fl o rida Age n c i es of Orlando, Inc. Pr es i d e n t / O w n e r Chief Financial Officer Longwood, FL James Cox KPH Construction, Corp. BioSafe Medical Tech n o l o g i es, Inc. Pr es i d e n t Wau k esha, WI Ch i cago, IL Na tional Board of Tru s te e s Dallas Mecha n i cal Air Sys t e m s Dallas, TX Kathleen Hays, RN, MN Diana Lee Bruce H. Allen Di r e c t o r, Inpatient Oncology Servi c es Wichita, KS Vice Presi d e n t Kathryn C. Danella Uni v e rsity of Pittsburgh Cancer Institute Su n Trust Bank Vice President and General Manager Uni v e rsity of Pittsburgh Medical Center Lynna M. Lesko, MD, PhD Delray Beach, FL Bo ca Pointe Community Association, Inc. Pittsburgh, PA Senior Associate Director Bo ca Raton, FL In t e rnational Clinical Rese a r ch Fay Allen Pat r i ck J. Healy, PhD General Medicine Division State Farm Insurance David S. Dimling Senior Vice President Bo e h ringer Ingelheim Pharma c e u t i cals, Inc. Je f f e rsonville, IN Board of Adv i s o rs Finance and Adm i n i s t r a t i o n Ridgefield, CT Equity Capital Par t n e rs, Inc. Quinnipiac College Scott W. Allison Atlanta, GA Hamden, CT Mi chael W. Long, PhD Senior Vice Presi d e n t Pr o f es s o r, Department of Ped i a t ri c s Co n n o rs Communicat i o n s Cynthia M. Driscoll Gary D. Hirsch Me m be r, Comprehensive Cancer Center San Francisco, CA Finance Manager Ch a i rm a n Uni v e rsity of Michigan Medical Center Women & Infants Hospital of Rhode Island Elk Capital, LLC Ann Arbor, MI Stephen M. Bailey Providence, RI Rye, NY Att o rn e y - a t - L a w Pasquale M. Lovas c i o Littleton, CO Terri S. Edlund Lynn C. Hoover Huntington Station, NY Vice Presi d e n t Mo r rison & Hecke r, LLP Irwin D. Bernstein, MD Bank of America Kansas City, MO Mark E. Mason Program Head, Ped i a t ric Oncology Program San Antonio, TX Vice Chairma n Fred Hutchinson Cancer Rese a r ch Center An t h o ny L. Huffman Oxford Development Company Seattle, WA Lawrence D. Ellis, MD Pr es i d e n t / O w n e r Pittsburgh, PA Pr o f essor of Medicine Huffman & Company, CPA Joseph E. Besecker Uni v e rsity of Pittsburgh Ja ckson, MS Catherine M. Mattson Ch a i rman, President, and CEO Pittsburgh, PA Market Development Manager Emerald Asset Management Thomas F. Hunter Hewlett Pack a r d La n ca s t e r, PA Stephen G. Emerson, MD, PhD Pr esident & COO Roseville, CA Chief, Hematology-Oncology Frequency Marketing, Inc. Janis L. Biermann, MS Uni v e rsity of Pennsylvania School of Medicine Milford, OH Ronald P. McCaffrey, MD Di r e c t o r, National Folic Acid Campaign Philadelphia, PA Di r e c t o r, The Cancer Center Ma r ch of Dimes Birth Defects Foundation William Ianniello Lowell General Hosp i t a l White Plains, NY Ri chard C. Ficke n Pr es i d e n t Lowell, MA Di ck Ficken & Associates, Inc. Pr o f essional Painting, Inc. Alexandra Mayes Birnbaum Eden Prairie, MN New Haven, CT Thomas R. McDonald New York, NY Tucson, AZ Thomas L. Fit z p a t r i ck Anne K. Johnson M. O. Breeding Manager of Corporate Credit Senior Lending Officer John R. Mohr Oklahoma City, OK Saint Gobain Corporation CTX Mortgage Pr es i d e n t Wor c es t e r, MA Sarasota, FL JRM Communicat i o n s Wilburn Brewer, Jr. Cold Spring Harbor, NY Par t n e r Frances M. Fox, RN, MSN Nexsen Pruet Jacobs & Pollard, LLP Certified School Nurse Columbia, SC Mt. Laurel, NJ Senior staff
Dennis F. Moore, MD, FACP Thomas J. Scanlon Dwayne Howel l Research & Medical Program s Ch a i rman, Department of Hematology- Managing Par t n e r Pr esident and CEO Me d i cal Oncology Donahue & Scan l o n Marshall A. Lichtman, MD Wichita Clinic, PA Cleveland, OH Ad m i n i s tra ti o n Executive Vice Presi d e n t Wichita, KS Res e a r ch & Medical Programs Rhonda Sheakley Cynthia Gardner Cross Virginia S. Morris Cincinnati, OH Vice President Alan Kinniburgh, PhD Medina, WA Adm i n i s t r a t i o n Vice Presi d e n t Frank T. Short Res e a r ch Adm i n i s t r a t i o n Suzanne J. Muntzing Go v e rnment Servi c es Director Ch a p ter Development Wealth Management Specialist Leagre Chandler and Millard Revenue Development Wells Far g o Indianapolis, IN Paul Wei s s San Francisco, CA Senior Vice President Ri chard J. Geswel l Norbert J. Sieber Chapter Development Senior Vice Presi d e n t Rodman N. Myer s Executive Vice Presi d e n t Revenue Development Of Counsel MARC Adv e r t i s i n g Phil Boudreau Honigman Miller Schwartz and Cohn Pittsburgh, PA Regional Director Greg Elfers Detroit, MI We st e rn Region Vice Presi d e n t Kay H. Singer, PhD Campaign Development Judge Robert H. Newman Assistant Dean Linda Gruskiewicz Miami Beach, FL Duke Uni v e rs i t y Regional Director Durham, NC Ea s t e rn Region Andrew E. Nolan Par t n e r Thomas R. Snyde r Pamela Byrne Riley Pri c e w a t e r h o u s e C o o p e rs LLP First Vice Presi d e n t Regional Director New York, NY Su n Trust Bank, Nashville, NA Mi d w est Region Nashville, TN Mary J. Oyer Kat hy Vro m a n Northfield, IL James E. Sparkes Regional Director Managing Par t n e r, Syr a c u s e So u t h e rn Region & Major Media Markets Dominic Pino Ha r ris Beach & Wil c ox, LLP Par t n e r Syracuse, NY Fi n a n c e/I n f o r m a tion Tec h n o l o gy Pri c e w a t e r h o u s e C o o p e rs LLP Ft. Lauderdale, FL Grant E. Stebner John Wal t e r Tigard, OR Senior Vice President David G. Pop l a ck, MD Finance & Information Tech n o l o g y Director Jeffrey N. Tre n t o n Texas Children’s Cancer Center Pr es i d e n t Ji m my Nangle Houston, TX Proficiency Capital Corporation Vice President & Controller Los Angeles, CA Fin a n c e David B. Quinty Senior Resident Vice Presi d e n t Joseph D. Verdirame, MD Stephen B. Lucas Me r rill Lyn ch Hematology & Oncology Consultants, PC Chief Information Officer Bi rmingham, AL Omaha, NE Government & Legi s l a tive Affairs Martin Rau ch William M. Ward, Jr. Ow n e r Pr esident and CEO George Dahlman RE/MAX Schoolside REALTO R S Pr es b y t e rian Manors of Mid-America Vice President Ch eshire, CT Wichita, KS Public Pol i c y
William H. Rei m e r s Owen N. Witte, MD Ma r k e ting & Communicatio n s Regional Sales Manager David Saxon Presidential Chair Bowman Enterpris es, Inc. in Developmental Immunology Robert K. Weh r m a n n Ja cksonville, NC Howard Hughes Medical Institute/UCLA Senior Vice Presi d e n t Los Angeles, CA Marketing & Strategy Development Marcie Rehmar Rog e l l Community Educat i o n Judge Robert M. Yac o b i Mi chael F. Aldrich Ch i l d r e n ’s Hosp i t a l Williamsburg, VA Vice Presi d e n t Columbus, OH Marketing and Product Development Joseph Yur f e s t Naomi Rosenberg, PhD CWF Project Director Kenneth R. Lightcap Pr o f es s o r Ca r e Fi rst Blue Cross Blue Shield Vice Presi d e n t Tufts Uni v e rsity School of Medicine Timonium, MD Co m m u n i ca t i o n s Boston, MA Patient Servi c e s Kevin R. Ryan Yam p o l s k y, Mandeloff, Silver & Co. Robin Kornhaber, MSW Philadelphia, PA Vice Presi d e n t Patient Servi c es Donald H. Salsbery Director of Fin a n c e UFCW Washington, DC Chapter offices (alphabetical by state)
Alabama Florida Louisiana New Mexico
Alabama Chapter Central Florida Chapter Louisiana Chapter New Mexico Chapter 100 Chase Park South, Suite 22 0 3319 Maguire Blvd., Suite 101 3636 South I-10 Service Rd., Suite 304 3150 Carlisle, N.E., Suite 35 Birmingham, AL 35244 Orlando, FL 32803 Metairie, LA 70001 Albuquerque, NM 87110 Phone: (205) 989-0098 Phone: (407) 898-0733 Phone: (504) 837-0945 Phone: (505) 830-6040
Arizona Northern Florida Chapter Maryland New York 9143 Phillips Highway Desert Mountain States Chapter Suite 130, Exchange South Maryland Chapter Central New York Chapter 2990 E. Northern Avenue, E-100 Jacksonville, FL 32256 8600 LaSalle Road Learbury Centre, 401 N. Salina Street Phoenix, AZ 85028 Phone: (904) 398-4845 Chester Building, Suite 314 Syracuse, NY 13203-1770 Phone: (602) 788-8622 Baltimore, MD 21286-2011 Phone: (315) 471-1050 Palm Beach Area Chapter Phone: (410) 825-2500 California 4360 Northlake Boulevard, Suite 10 9 Long Island Chapter Palm Beach Gardens, FL 33410 Massachusetts 555 Broad Hollow Road Greater Los Angeles Chapter Phone: (561) 775-9954 Melville, NY 11747 100 Corporate Pointe, Suite 18 0 Massachusetts Chapter Phone: (631) 752-8500 Culver City, CA 9023 0 Southern Florida Chapter 495 Old Connecticut Path, Suite 220 Phone: (310) 348-5721 3325 Hollywood Boulevard, Suite 400 Framingham, MA 01701-4567 New York City Chapter Hollywood, FL 33021 Phone: (508) 879-5083 475 Park Avenue South, 21st Floor Northern California Chapter Phone: (954) 458-105 0 New York, NY 10016 1390 Market Street, Suite 1200 Michigan Phone: (212) 448-9206 San Francisco, CA 9 4102-5306 Suncoast Chapter Phone: (415) 625-1100 13907 N. Dale Mabry Highway, Suite 101 Michigan Chapter Upstate New York/Vermont Chapter Tampa, FL 33618 1421 E. Twelve Mile Road, Bldg. A 6 Automation Lane Greater Sacramento Area Chapter Phone: (813) 963-6461 Madison Heights, MI 4 8071 Albany, NY 12205 3105 Fite Circle, Suite 101 Phone: (248) 582-2900 Phone: (518) 438-3583 Sacramento, CA 95827 Georgia Phone: (916) 369-7581 Minnesota Westchester & Hudson Valley Chapter Georgia Chapter 20 Haarlem Avenue San Diego/Hawaii Chapter 2625 Cumberland Parkway, Suite 205 Minnesota Chapter White Plains, NY 10603 4715 Viewridge Avenue, Suite 110 Atlanta, GA 30339 5217 Wayzata Blvd., Suite 221 Phone: (914) 949-0084 San Diego, CA 92123 Phone: (770) 438-6006 St. Louis Park, MN 55416 Phone: (858) 277-1800 Phone: (612) 545-3309 Western New York & Finger Lakes Illinois Chapter Tri-County Chapter Mississippi 5500 Main Street, Suite 110 1744 W. Katella, Suite 8 Illinois Chapter Williamsville, NY 14221 Orange, CA 92867 100 W. Monroe, Suite 1610 Mississippi Chapter Phone: (716) 635-9111 Phone: (714) 633-6858 Chicago, IL 60603 405 Fontaine Place, Suite 103 Phone: (312) 726-0003 Ridgeland, MS 39157 North Carolina Colorado Phone: (601) 956-7447 Indiana North Carolina Chapter Rocky Mountain Chapter Missouri 5950 Fairview Road, Suite 25 0 5353 W. Dartmouth Avenue Indiana Chapter Charlotte, NC 28210 Denver, CO 80227 921 E. 86th Street, Suite 205 The Gateway Chapter Phone: (704) 998-5012 Phone: (303) 984-2110 Indianapolis, IN 46240 77 West Port Plaza, Suite 101 Phone: (317) 726-2270 St. Louis, MO 63146-3111 Ohio Connecticut Phone: (314) 878-0780 Kansas Central Ohio Chapter Connecticut Chapter Nebraska 145 North High Street, Suite 800 300 Research Parkway, Suite 310 Kansas Chapter Columbus, OH 43215 Meriden, CT 06450 555 N. Woodlawn, Bldg. 1, Suite 113 Nebraska Chapter Phone: (614) 221-3129 Phone: (203) 379-0445 Wichita, KS 67208 2665 Farnam Street Phone: (316) 687-2222 Omaha, NE 68131 Northern Ohio Chapter Fairfield County Chapter Phone: (402) 3 44-2242 20525 Center Ridge Road, Suite 630 25 Third Street, 4th Floor Mid-America Chapter Cleveland, OH 44116 Stamford, CT 06905 6811 West 63rd Street New Jersey Phone: (440) 333-5033 Phone: (203) 967-8326 Cloverleaf Building #1, Suite 202 Shawnee Mission, KS 66202-4001 Northern New Jersey Chapter Southern Ohio Chapter Delaware Phone: (800) 256-1075 45 Springfield Avenue Fourth and Race Towers Springfield, NJ 07081 105 West Fourth Street, Suite 900 Delaware Chapter Kentucky Phone: (973) 376-9559 Cincinnati, OH 45202 100 West 10th Street, Suite 209 Phone: (513) 361-2100 Wilmington, DE 19801 Kentucky Chapter Southern New Jersey Chapter Phone: (302) 661-7300 710 West Main Street, Suite 201 216 Haddon Avenue, Suite 328 Oklahoma Louisville, KY 40202-2690 Westmont, NJ 08108 District of Columbia Phone: (502) 584-8490 Phone: (856) 869-0200 Oklahoma Chapter 3613 N.W. 56th Street, Suite 230 National Capital Area Chapter Oklahoma City, OK 73112-4520 5845 Richmond Highway, Suite 630 Phone: (405) 943-8 888 Alexandria, VA 22303 Phone: (703) 960-1100 Oregon Washington
Oregon Chapter Washington/Alaska Chapter 6501 S.W. Macadam Avenue 2030 Westlake Avenue Portland, OR 97201 Seattle, WA 98121 Phone: (503) 245-9 866 Phone: (206) 628-0777
Pennsylvania Wisconsin
Central Pennsylvania Chapter Wisconsin Chapter 800 Corporate Circle, Suite 100 1126 South 70th Street, Suite N405A Harrisburg, PA 17110 Milwaukee, WI 53214 Phone: (717) 652-6520 Phone: (414) 256-4020
Eastern Pennsylvania Chapter 2401 Pennsylvania Avenue, Suite 2-D-1 Philadelphia, PA 19130 Phone: (215) 232-1100
Western Pennsylvania & West Virginia Chapter Two Gateway Center, 13 North Pittsburgh, PA 15222 Phone: (412) 395-2873
Rhode Island
Rhode Island Chapter 75 Sockanosset Crossroad Suite 206 - Box 8099 Cranston, RI 02920 Phone: (401) 943-8888
South Carolina
South Carolina Chapter 1247 Lake Murray Boulevard Irmo, SC 29063 Phone: (803) 749-4299
Tennessee
Tennessee Chapter 446 Metroplex Drive, Suite A-200 Nashville, TN 37211-3139 Phone: (615) 331-2 980
Texas
North Texas Chapter 12850 Spurling Drive, Suite 190 Dallas, TX 75230 Phone: (972) 239-0959
South/West Texas Chapter 950 Isom Road, Suite 10 4 San Antonio, TX 78216 Phone: (210) 377-1775
Texas Gulf Coast Chapter 10777 N.W. Freeway, Suite 600 Houston, TX 77092 Phone: (713) 680-8088
Virginia
Virginia Chapter 2101 Executive Drive, Tower Box 21 Hampton, VA 23666 Phone: (757) 838-9351 Helping the Society through effective personal financial planning
There are several convenient ways you can direct your personal financial plans to support the fight against blood-related cancers:
• Include The Leukemia & Lymphoma Society in your will and leave a lasting legacy. You can direct gifts to be made in a specific amount, a percentage of your estate, or the remainder of your estate.
• Include The Leukemia & Lymphoma Society in your estate plans, an d become a member of The Leg a cy Circl e. Members receive regular up d a t e s on the progress being made in the fight against blood-related cancers and are invited to attend meetings with researchers.
• Consult with The Leukemia & Lymphoma Society to find out the best way to use your trust, insurance policy or other estate planning technique in the fight against blood-related cancers.
For more information, contact the Society’s National Director of Planned Giving at 1. 8 0 0 . 7 73 . 9 9 5 8 . Contactwww.leukemia-lymphoma.org Fax: 914.949.6691 Tel: 914.949.5213 10605 NY Plains, White 1311 MamaroneckAvenue